EP3886854A4 - Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung - Google Patents
Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung Download PDFInfo
- Publication number
- EP3886854A4 EP3886854A4 EP19889878.5A EP19889878A EP3886854A4 EP 3886854 A4 EP3886854 A4 EP 3886854A4 EP 19889878 A EP19889878 A EP 19889878A EP 3886854 A4 EP3886854 A4 EP 3886854A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pyrrole
- methods
- pyrazole compounds
- pyrazole
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774056P | 2018-11-30 | 2018-11-30 | |
| PCT/US2019/063742 WO2020113094A1 (en) | 2018-11-30 | 2019-11-27 | Pyrrole and pyrazole compounds and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3886854A1 EP3886854A1 (de) | 2021-10-06 |
| EP3886854A4 true EP3886854A4 (de) | 2022-07-06 |
Family
ID=70853079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19889878.5A Withdrawn EP3886854A4 (de) | 2018-11-30 | 2019-11-27 | Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11034669B2 (de) |
| EP (1) | EP3886854A4 (de) |
| AU (1) | AU2019387370A1 (de) |
| CA (1) | CA3121202A1 (de) |
| IL (1) | IL283369A (de) |
| WO (1) | WO2020113094A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11292782B2 (en) | 2018-11-30 | 2022-04-05 | Nuvation Bio Inc. | Diarylhydantoin compounds and methods of use thereof |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| KR20220008869A (ko) | 2019-05-14 | 2022-01-21 | 누베이션 바이오 인크. | 항암 핵 호르몬 수용체-표적화 화합물 |
| EP4058464A1 (de) | 2019-11-13 | 2022-09-21 | Nuvation Bio Inc. | Auf nuklearhormonrezeptor abzielende antikrebsverbindungen |
| IL306010A (en) | 2021-03-23 | 2023-11-01 | Nuvation Bio Inc | Anticancer compounds against the nuclear hormone receptor |
| WO2022235585A1 (en) * | 2021-05-03 | 2022-11-10 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010017902A1 (de) * | 2008-08-14 | 2010-02-18 | Bayer Cropscience Aktiengesellschaft | Insektizide 4-phenyl-1h-pyrazole |
| WO2017123542A1 (en) * | 2016-01-11 | 2017-07-20 | Janssen Pharmaceutica Nv | Substituted thiohydantoin derivatives as androgen receptor antagonists |
Family Cites Families (1050)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH641470A5 (de) | 1978-08-30 | 1984-02-29 | Ciba Geigy Ag | Imidgruppen enthaltende silane. |
| DE2930031C2 (de) | 1979-07-24 | 1985-05-02 | Mitsui Toatsu Chemicals, Inc., Tokio/Tokyo | Wärmehärtbare Harzzusammensetzung |
| US4539161A (en) | 1980-07-25 | 1985-09-03 | Ciba-Geigy Corporation | Amine oxide compounds |
| DE3134942A1 (de) | 1981-09-03 | 1983-03-17 | Bayer Ag, 5090 Leverkusen | Aufhellersalze und deren verwendung fuer das nassspinnen von acrylfasern |
| US4824859A (en) | 1983-05-21 | 1989-04-25 | Fisons Plc. | Pyrazoline compounds compositions and use |
| JPS6046555A (ja) | 1983-08-24 | 1985-03-13 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
| US4554086A (en) | 1984-04-26 | 1985-11-19 | Texaco Inc. | Borate esters of hydrocarbyl-substituted mono- and bis-succinimides containing polyamine chain linked hydroxyacyl groups and lubricating oil compositions containing same |
| GB8506803D0 (en) | 1985-03-15 | 1985-04-17 | Ciba Geigy Ag | Developing agents |
| JPS6218462A (ja) | 1985-07-16 | 1987-01-27 | Mitsui Petrochem Ind Ltd | ポリエステル組成物 |
| JPS6254739A (ja) | 1985-09-04 | 1987-03-10 | Sumitomo Chem Co Ltd | 加硫促進剤 |
| JPS6271965A (ja) | 1985-09-26 | 1987-04-02 | Fuji Photo Film Co Ltd | 電子写真感光材料 |
| DE3535247A1 (de) | 1985-10-03 | 1987-04-09 | Agfa Gevaert Ag | Farbfotografisches aufzeichnungsmaterial mit leicht dispergierbaren farbkupplern |
| US5081131A (en) | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| IT1204416B (it) | 1986-06-27 | 1989-03-01 | Midy Spa | Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini |
| DE3718317A1 (de) | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| DE3716293A1 (de) | 1987-05-15 | 1988-11-24 | Basf Ag | Verfahren zur herstellung von pyrazolen |
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US4892578A (en) | 1987-11-06 | 1990-01-09 | Fmc Corporation | Phenylmethyl-4,4-dimethyl-3-isoxazolidinone plant regulators |
| EP0318214B1 (de) | 1987-11-20 | 1994-12-14 | Schering Corporation | Tri- und tetrasubstituierte Oxetane und Tetrahydrofurane und deren Zwischenprodukte |
| US5096919A (en) | 1989-01-05 | 1992-03-17 | Ciba-Geigy Corporation | Pyrrolylphenyl-substituted hydroxamic acid derivatives |
| JP2604221B2 (ja) | 1989-01-10 | 1997-04-30 | 富士写真フイルム株式会社 | 拡散転写法用感光要素 |
| DE3903993A1 (de) | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
| JPH0324540A (ja) | 1989-06-21 | 1991-02-01 | Konica Corp | ハロゲン化銀カラー写真感光材料 |
| JPH03192250A (ja) | 1989-12-21 | 1991-08-22 | Konica Corp | ハロゲン化銀写真感光材料 |
| US5049577A (en) | 1990-01-29 | 1991-09-17 | E. R. Squibb & Sons, Inc. | 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith |
| US5447947A (en) | 1990-02-26 | 1995-09-05 | Arc 1 | Compositions and methods of treatment of sympathetically maintained pain |
| US5063245A (en) | 1990-03-28 | 1991-11-05 | Nova Pharmaceutical Corporation | Corticotropin-releasing factor antagonism compounds |
| JPH05505822A (ja) | 1990-03-30 | 1993-08-26 | メルク・エンド・カムパニー・インコーポレーテツド | ピラゾール類、イソキサゾール類及びイソチアゾール置換体 |
| DE4010797A1 (de) | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
| US5093499A (en) | 1990-04-09 | 1992-03-03 | Shell Oil Company | Spirodilactam derivatives |
| JP2638253B2 (ja) | 1990-04-20 | 1997-08-06 | 株式会社バイオセンサー研究所 | ビタミンｄ類定量用試薬およびその製法 |
| FR2665440B1 (fr) | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
| US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
| US5091291A (en) | 1990-10-25 | 1992-02-25 | Eastman Kodak Company | Alkyl substituted photographic couplers and photographic elements and processes employing same |
| DE4036706A1 (de) | 1990-11-17 | 1992-05-21 | Hoechst Ag | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
| JPH04204938A (ja) | 1990-11-30 | 1992-07-27 | Konica Corp | ハロゲン化銀写真感光材料 |
| CA2099591C (en) | 1990-12-05 | 2002-11-12 | Rajeshwar Singh | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents |
| US5342846A (en) | 1990-12-05 | 1994-08-30 | Synphar Laboratories, Inc. | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents |
| US5175180A (en) | 1990-12-20 | 1992-12-29 | G. D. Searle & Co. | N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders |
| DE4107857A1 (de) | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5321034A (en) | 1991-05-07 | 1994-06-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| IT1247977B (it) | 1991-06-04 | 1995-01-05 | Ciba Geigy Spa | Stabilizzazione di materiali organici polimerici mediante l`impiego dimiscele sinergiche costituite da ammine cicliche stericamente impeditee derivati del 3-pirazolidinone o del 1,2,4,-triazolidin-3,5,-dione |
| JPH07100687B2 (ja) | 1991-06-13 | 1995-11-01 | ファイザー製薬株式会社 | 新規なｎ−ヒドロキシ尿素化合物および組成物 |
| US5508407A (en) | 1991-07-10 | 1996-04-16 | Eli Lilly And Company | Retroviral protease inhibitors |
| US5266454A (en) | 1991-07-22 | 1993-11-30 | Eastman Kodak Company | Solid particle dispersions of filter dyes for photographic elements |
| DE4124942A1 (de) | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JP3113678B2 (ja) | 1991-08-22 | 2000-12-04 | ワーナー−ランバート・コンパニー | アミドテトラゾールａｃａｔ阻害剤 |
| US5366987A (en) | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
| US5484937A (en) | 1992-08-04 | 1996-01-16 | G.D. Searle & Co. | N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders |
| US5270145A (en) | 1991-12-06 | 1993-12-14 | Eastman Kodak Company | Heat image separation system |
| GB2263638A (en) | 1992-01-28 | 1993-08-04 | Merck & Co Inc | Substituted pyrazoles, isoxazoles and isothiazoles as neurotensin antagonists |
| PL173789B1 (pl) | 1992-02-05 | 1998-04-30 | Boehringer Ingelheim Kg | Sposób wytwarzania nowych pochodnych amidyny |
| US5221676A (en) | 1992-02-06 | 1993-06-22 | Warner-Lambert Company | 7-substituted quinolones and naphthyridones as antibacterial agents |
| AU2003200066B9 (en) | 1992-03-11 | 2007-02-15 | Narhex Limited | Amine Derivatives of Oxo- and Hydroxy-substituted Hydrocarbons |
| US5852192A (en) | 1992-03-11 | 1998-12-22 | Dr. Karl Thomae Gmbh | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| DE4213931A1 (de) | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE69310730T2 (de) | 1992-04-29 | 1997-10-30 | Akzo Nobel Nv | Antimüdungsmittel für kautschukvulkanisate |
| US5346908A (en) | 1992-06-25 | 1994-09-13 | National Institutes Of Health | Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders |
| US20090191227A1 (en) | 2007-05-23 | 2009-07-30 | Vical Incorporated | Compositions and Methods for Enhancing Immune Responses to Vaccines |
| JPH0651441A (ja) | 1992-07-27 | 1994-02-25 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| US5239082A (en) | 1992-08-03 | 1993-08-24 | Warner-Lambert Company | Sulfonamide tetrazole ACAT inhibitors |
| US5283163A (en) | 1992-12-18 | 1994-02-01 | Eastman Kodak Company | Photographic material and process employing a development inhibitor releasing compound containing a fluorinated carbon alpha to an amide group |
| DE4308034A1 (de) | 1993-03-13 | 1994-09-15 | Cassella Ag | Neue Heterocyclen, ihre Herstellung und ihre Verwendung |
| WO1994022846A1 (en) | 1993-03-30 | 1994-10-13 | Pfizer Inc. | Compounds enhancing antitumor activity of other cytotoxic agents |
| US5451597A (en) | 1993-05-27 | 1995-09-19 | G.D. Searle & Co. | Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists |
| DE4427979A1 (de) | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
| US5401765A (en) | 1993-11-30 | 1995-03-28 | G. D. Searle | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| US5543259A (en) | 1993-12-13 | 1996-08-06 | Xerox Corporation | Developer compositions |
| FR2714378B1 (fr) | 1993-12-24 | 1996-03-15 | Sanofi Sa | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. |
| GB9413270D0 (en) | 1994-07-01 | 1994-08-24 | Ciba Geigy Ag | Textile treatment |
| US5559137A (en) | 1994-05-16 | 1996-09-24 | Smithkline Beecham Corp. | Compounds |
| US5461049A (en) | 1994-05-27 | 1995-10-24 | Warner-Lambert Company | Amide tetrazole ACAT inhibitors |
| DE4423444A1 (de) | 1994-07-05 | 1996-01-11 | Bayer Ag | Verfahren zur Herstellung von farbigen nativen oder synthetischen Substraten |
| PT783505E (pt) | 1994-09-29 | 2001-08-30 | Novartis Ag | Pirrolo¬2,3-d|pirimidinas e sua utilizacao |
| US5503940A (en) | 1994-10-24 | 1996-04-02 | The Goodyear Tire & Rubber Company | Elastomeric laminates containing a solventless elastomeric adhesive composition |
| US5510379A (en) | 1994-12-19 | 1996-04-23 | Warner-Lambert Company | Sulfonate ACAT inhibitors |
| US5746821A (en) | 1995-02-13 | 1998-05-05 | Engelhard Corporation | Pigment compositions |
| US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| EP0828718A1 (de) | 1995-06-02 | 1998-03-18 | G.D. SEARLE & CO. | Heterocyclo-substituierte hydroxaminsäurederivate als cyclooxygenase-2 und 5-lipoxygenase inhibitoren |
| US6034093A (en) | 1995-06-07 | 2000-03-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| RU2166330C2 (ru) | 1995-06-07 | 2001-05-10 | Джи. Ди. Сирл Энд Ко. | Комбинация, содержащая антагонист рецептора ангиотензина ii и эпоксистероидный антагонист рецептора альдостерона |
| US5612353A (en) | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| US5731315A (en) | 1995-06-07 | 1998-03-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds |
| AU5982296A (en) | 1995-06-07 | 1996-12-30 | G.D. Searle & Co. | Method to treat cardiofibrosis with a combination of an angi otensin ii antagonist and spironolactone |
| CZ291268B6 (cs) | 1995-06-07 | 2003-01-15 | G. D. Searle & Co. | Farmaceutická kombinace |
| CA2162457A1 (en) | 1995-06-26 | 1996-12-27 | Neil Arthur Maly | Sulfur vulcanizable rubber compound |
| US5942379A (en) | 1995-08-10 | 1999-08-24 | Eastman Kodak Company | 3-pyrazolidone compounds and photographic developer solutions containing same |
| FR2737722B1 (fr) | 1995-08-10 | 1997-09-05 | Kodak Pathe | Composes du type 3-pyrazolidone utiles en photographie |
| US6130217A (en) | 1995-09-20 | 2000-10-10 | Pfizer Inc | Compounds enhancing antitumor activity of other cytotoxic agents |
| JP3994453B2 (ja) | 1995-10-13 | 2007-10-17 | 日産化学工業株式会社 | ピラゾロン類 |
| CA2229617A1 (en) | 1995-10-20 | 1997-05-01 | Dr. Karl Thomae Gmbh | 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
| HUP9900927A3 (en) | 1995-11-17 | 2002-02-28 | Aventis Pharmaceuticals Inc Br | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| US6211199B1 (en) | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| WO1997020823A2 (en) | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
| WO1997020822A1 (en) | 1995-12-01 | 1997-06-12 | Novartis Ag | Quinazolin-2,4-diazirines as npy receptor antagonist |
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| EP0874843B1 (de) | 1995-12-20 | 2002-08-07 | Aventis Pharmaceuticals Inc. | Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten |
| DE19600634A1 (de) | 1996-01-10 | 1997-07-17 | Dystar Textilfarben Gmbh & Co | Verfahren zur Herstellung von farbigen nativen oder synthetischen Substraten und deren Nachbehandlung |
| ATE227269T1 (de) | 1996-01-30 | 2002-11-15 | Takeda Chemical Industries Ltd | 1-arylpyrazole insektizide |
| FR2746391B1 (fr) | 1996-03-22 | 1998-04-17 | Oreal | Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations |
| DE19611476A1 (de) | 1996-03-22 | 1997-09-25 | Basf Ag | Neue heterocyclische substituierte Imidazolo-chinoxalinone, ihre Herstellung und Verwendung |
| US6001835A (en) | 1996-04-03 | 1999-12-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| EP0891356A1 (de) | 1996-04-03 | 1999-01-20 | Merck & Co., Inc. | Inhibitoren von farnesylprotein-transferase |
| US5859035A (en) | 1996-04-03 | 1999-01-12 | Merck & Co., Inc. | Arylheteroaryl inhibitors of farnesyl-protein transferase |
| CA2249639A1 (en) | 1996-04-03 | 1997-10-09 | Neville J. Anthony | Inhibitors of farnesyl-protein transferase |
| US5854265A (en) | 1996-04-03 | 1998-12-29 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
| US5723104A (en) | 1996-05-13 | 1998-03-03 | Fung; Ella Y. | Monocyclic functional dyes for contrast enhancement in optical imaging |
| GB9610563D0 (en) | 1996-05-20 | 1996-07-31 | Bp Chemicals Additives | Marine diesel process and fuel therefor |
| JPH09328463A (ja) | 1996-06-07 | 1997-12-22 | Nissan Chem Ind Ltd | セミカルバゾン誘導体及び有害生物防除剤 |
| FR2750225B1 (fr) | 1996-06-24 | 1999-09-24 | Kodak Pathe | Composition de developpement photographique |
| AU3176297A (en) | 1996-06-25 | 1998-01-14 | Novartis Ag | Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof |
| EP0934265B1 (de) | 1996-08-16 | 2003-01-02 | Bristol-Myers Squibb Pharma Company | Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate |
| FR2753812B1 (fr) | 1996-09-25 | 2004-01-16 | Kodak Pathe | Revelateurs photographiques contenant un developpateur de type acide ascorbique et un accelerateur |
| US5908934A (en) | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| PL323130A1 (en) | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
| DE19647380A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
| DE19647381A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
| DE19650975A1 (de) | 1996-12-09 | 1998-06-10 | Basf Ag | Neue heterocyclisch substituierte Benzamide und deren Anwendung |
| NZ336162A (en) | 1996-12-23 | 2000-09-29 | Du Pont Pharm Co | pyrrole, tetrazole or pyrazole derivatives useful as factor Xa inhibitors |
| US6020357A (en) | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
| US6093737A (en) | 1996-12-30 | 2000-07-25 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6169086B1 (en) | 1997-01-27 | 2001-01-02 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| US6093744A (en) | 1997-04-21 | 2000-07-25 | Warner-Lambert Company | N-acyl sulfamic acid esters useful as hypocholesterolemic agents |
| FR2763241B1 (fr) | 1997-05-13 | 1999-07-02 | Oreal | Composition de teinture des fibres keratiniques comprenant une pyrazolin-4,5-dione et une amine primaire aromatique |
| JP2002502380A (ja) | 1997-05-22 | 2002-01-22 | ジー．ディー．サール アンド カンパニー | ｐ３８キナーゼ阻害剤としてのピラゾール誘導体 |
| ZA984358B (en) | 1997-05-22 | 1999-05-24 | Searle & Co | Substituted pyrazoles as p38 kinase inhibitors |
| PL336990A1 (en) | 1997-05-22 | 2000-07-31 | Searle & Co | 3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38 |
| CA2290604A1 (en) | 1997-05-23 | 1998-11-26 | The Procter & Gamble Company | Hair colouring compositions and their use |
| US5965341A (en) | 1997-06-12 | 1999-10-12 | Eastman Kodak Company | Photographic element containing particular coupler combination |
| EP1023066A4 (de) | 1997-06-13 | 2001-05-23 | Smithkline Beecham Corp | Neue pyrazole- und pyrazoline- substituierte verbindung |
| US5998424A (en) | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| US6339099B1 (en) | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
| DE19728326A1 (de) | 1997-06-27 | 1999-01-07 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| FR2768733B1 (fr) | 1997-09-19 | 1999-10-29 | Oreal | Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques |
| JPH11171702A (ja) | 1997-09-24 | 1999-06-29 | Takeda Chem Ind Ltd | 害虫防除方法 |
| HUP9903500A3 (en) | 1997-09-26 | 2000-03-28 | Encysive Pharmaceuticals Inc | Thiophene-, furane- and pyrrolesulfonamides, their use and pharmaceutical compositions containing them |
| AU1031199A (en) | 1997-10-07 | 1999-04-27 | Rhone-Poulenc Agro | Methode of insect control |
| GB9723853D0 (en) | 1997-11-12 | 1998-01-07 | Zeneca Ltd | Compound, composition and use |
| EP1042299A1 (de) | 1997-12-22 | 2000-10-11 | Du Pont Pharmaceuticals Company | Stickstoffenthaltende heteroaromaten mit ortho-substituierten p1 gruppen als faktor-xa-inhibitoren |
| BR9908044A (pt) | 1998-01-30 | 2000-11-28 | First Chemical Corp | Composições de fotopolimerização incluindo maleimidas e processos para usar as mesmas |
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| JP2002509924A (ja) | 1998-03-27 | 2002-04-02 | デュポン ファーマシューティカルズ カンパニー | 第Ｘａ因子阻害剤としてのジ置換ピラゾリン類およびトリアゾリン類 |
| WO1999051580A1 (en) | 1998-04-08 | 1999-10-14 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
| DE19816929A1 (de) | 1998-04-16 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| JP2002512240A (ja) | 1998-04-20 | 2002-04-23 | ビーエーエスエフ アクチェンゲゼルシャフト | 複素環式置換基を有する新規アミド、その製造方法およびその使用 |
| AU4395399A (en) | 1998-07-02 | 2000-01-24 | Sankyo Company Limited | Five-membered heteroaryl compounds |
| WO2000005230A1 (fr) | 1998-07-24 | 2000-02-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de pyrazole et sels correspondants |
| AU5240099A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Heterocyclic sulphonamide derivatives |
| WO2000009503A1 (en) | 1998-08-13 | 2000-02-24 | Merck & Co., Inc. | Integrin receptor antagonists |
| WO2000025789A1 (en) | 1998-10-29 | 2000-05-11 | Merck & Co., Inc. | A method of treating endometriosis |
| GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
| US6207831B1 (en) | 1998-12-21 | 2001-03-27 | Novartis Ag | Fluorescent dyes (AIDA) for solid phase and solution phase screening |
| US7053139B2 (en) | 1998-12-30 | 2006-05-30 | Qi Wang | Inhibiting polymer oxidation using non-phenolic antioxidants |
| CA2361848A1 (en) | 1999-04-02 | 2000-10-12 | Dupont Pharmaceuticals Company | Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase |
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| US20010044445A1 (en) | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
| DE19918211A1 (de) | 1999-04-22 | 2000-10-26 | Basf Ag | Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung |
| AU4591500A (en) | 1999-05-05 | 2000-11-21 | Aventis Pharma Limited | Substituted pyrrolidines |
| DE19920936A1 (de) | 1999-05-07 | 2000-11-09 | Basf Ag | Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung |
| US6509361B1 (en) | 1999-05-12 | 2003-01-21 | Pharmacia Corporation | 1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors |
| US6503949B1 (en) | 1999-05-17 | 2003-01-07 | Noro Nordisk A/S | Glucagon antagonists/inverse agonists |
| CA2368827A1 (en) | 1999-06-16 | 2000-12-28 | Syngenta Participations Ag | New intermediates |
| PL201663B1 (pl) | 1999-06-16 | 2009-04-30 | Syngenta Participations Ag | Sposób wytwarzania chwastobójczych pochodnych 3-hydroksy-4-arylo-5-oksopirazolin |
| US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| IL137365A0 (en) | 1999-07-21 | 2001-07-24 | Sankyo Co | Heteroaryl-substituted pyrrole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| US6386255B1 (en) | 1999-07-30 | 2002-05-14 | The Goodyear Tire & Rubber Company | Tire repair patch including bis-imide compound |
| DE19937772A1 (de) | 1999-08-10 | 2001-02-15 | Bayer Ag | Substituierte Heterocyclyl-2GH-chromene |
| US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| US6617342B1 (en) | 1999-08-27 | 2003-09-09 | Eli Lilly And Company | Hypoglycemic sulfonyl pyrazolones and pyrazolines |
| ATE315934T1 (de) | 1999-09-10 | 2006-02-15 | Smithkline Beecham Corp | Thrombopoietin-mimetika |
| TWI263636B (en) | 1999-09-16 | 2006-10-11 | Ciba Sc Holding Ag | Fluorescent maleimides and use thereof |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| CN1374961A (zh) | 1999-09-28 | 2002-10-16 | 巴斯福股份公司 | 氮杂䓬吲哚衍生物,它们的制备和应用 |
| DE19946289A1 (de) | 1999-09-28 | 2001-03-29 | Basf Ag | Benzodiazepin-Derivate, deren Herstellung und Anwendung |
| CA2316129A1 (en) | 1999-10-05 | 2001-04-05 | The Goodyear Tire & Rubber Company | Synthetic rubber blend tire cushion |
| JP4861585B2 (ja) | 1999-10-29 | 2012-01-25 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 置換ピラゾールの合成方法 |
| CN1414848A (zh) | 1999-11-05 | 2003-04-30 | 沃尼尔·朗伯公司 | Acat抑制剂对斑块破裂的预防 |
| SE9904045D0 (sv) | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
| WO2001045745A2 (en) | 1999-12-21 | 2001-06-28 | Acambis Research Limited | A reversible linkage technology for controlled conjugation |
| JP2001181187A (ja) | 1999-12-27 | 2001-07-03 | Sankyo Co Ltd | ５員ヘテロアリール化合物を含有する組成物 |
| EP1254136A4 (de) | 2000-01-29 | 2005-06-01 | Lg Chem Investment Ltd | Arylamidine und derivate als faktor-xa-inhibitoren sowie deren pro-pharmaka |
| AU2001240542A1 (en) | 2000-02-01 | 2001-08-14 | Basf Aktiengesellschaft | Heterocyclic compounds and their use as parp inhibitors |
| IT1318423B1 (it) | 2000-03-24 | 2003-08-25 | Great Lakes Chemical Europ | Miscele stabilizzanti per polimeri organici. |
| AU5959201A (en) | 2000-05-11 | 2001-11-20 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| WO2002000651A2 (en) | 2000-06-27 | 2002-01-03 | Bristol-Myers Squibb Pharma Company | Factor xa inhibitors |
| US20020032238A1 (en) | 2000-07-08 | 2002-03-14 | Henning Priepke | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments |
| PL363960A1 (en) | 2000-07-17 | 2004-11-29 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| US6541639B2 (en) | 2000-07-26 | 2003-04-01 | Bristol-Myers Squibb Pharma Company | Efficient ligand-mediated Ullmann coupling of anilines and azoles |
| US6733958B2 (en) | 2000-08-30 | 2004-05-11 | Dainippon Ink And Chemicals, Inc. | Material for photo-alignment layer, photo-alignment layer and method of manufacturing the same |
| US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
| US20020098999A1 (en) | 2000-10-06 | 2002-07-25 | Gallop Mark A. | Compounds for sustained release of orally delivered drugs |
| GB0026560D0 (en) | 2000-10-30 | 2000-12-13 | Novartis Ag | Organic compounds |
| WO2002041984A2 (en) | 2000-11-01 | 2002-05-30 | The Board Of Trustees Of The Leland Stanford Junior University | Catalytic compositions and methods for asymmetric aldol reactions |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| US6693295B2 (en) | 2000-12-25 | 2004-02-17 | Fuji Photo Film Co., Ltd. | Indole derivative, material for light-emitting device and light-emitting device using the same |
| DE10100708A1 (de) | 2001-01-10 | 2002-07-11 | Oxeno Olefinchemie Gmbh | Neue N-Phenylpyrrolbisphosphanverbindungen und deren Metallkomplexe |
| EP1351936A1 (de) | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Arylpiperidin- und arylpiperazinderivate als induktoren der ldl-rezeptorexpression |
| JP2002284779A (ja) | 2001-01-18 | 2002-10-03 | Sankyo Co Ltd | ヘテロアリール置換ピロール誘導体を含有する医薬 |
| CA2435141A1 (en) | 2001-01-18 | 2002-07-25 | Sankyo Company, Limited | Compositions for prevention or treatment of hepatopathy |
| CA2369967A1 (en) | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| DE10109806A1 (de) | 2001-03-01 | 2002-09-05 | Wella Ag | Diaminopyrazol-Derivate und Pyrazolon-Derivate enthaltende Oxidationshaarfärbemittel |
| DE10109805A1 (de) | 2001-03-01 | 2002-09-05 | Wella Ag | Oxidationsfärbemittel |
| DE10109807A1 (de) | 2001-03-01 | 2002-09-05 | Wella Ag | Verbrückte Diaminopyrazole und diese Verbindungen enthaltende Färbemittel |
| JP4756296B2 (ja) | 2001-03-14 | 2011-08-24 | Ｄｉｃ株式会社 | マレイミド誘導体及びそれを用いた光配向膜の製造方法 |
| MXPA03008560A (es) | 2001-03-22 | 2004-06-30 | Abbot Gmbh & Co Kg | Pirazolopirimidinas como agentes terapeuticos. |
| CN1259316C (zh) | 2001-04-05 | 2006-06-14 | 托伦脱药品有限公司 | 用于老龄相关性和糖尿病性血管系统并发症的杂环类化合物 |
| CA2446387A1 (en) | 2001-05-09 | 2002-11-14 | Sumitomo Chemical Takeda Agro Company, Limited | Azole compound, process for producing the same and use thereof |
| US20030092736A1 (en) | 2001-05-30 | 2003-05-15 | Cheng Peter T. | Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| AU2002346048A1 (en) | 2001-06-07 | 2002-12-16 | Merck And Co., Inc. | Benzodiazepine bradykinin antagonists |
| EP1406632A4 (de) | 2001-06-08 | 2009-11-04 | Cytovia Inc | Substituierte 3-aryl-5-aryl- 1,2,4 -oxadiazole und analoga als aktivatoren von caspases und apoptose-induktoren und ihre verwendung |
| KR20040007714A (ko) | 2001-06-14 | 2004-01-24 | 버텍스 파마슈티칼스 인코포레이티드 | 신경 손상 치료에 유용한 비환식 피페라진 및 피페리딘유도체 |
| WO2003000685A1 (en) | 2001-06-20 | 2003-01-03 | Takeda Chemical Industries, Ltd. | 5-membered heterocycle derivatives |
| WO2003000249A1 (fr) | 2001-06-26 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Regulateur de la fonction du recepteur relatif aux retinoides |
| IL159811A0 (en) | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| WO2003011837A1 (en) | 2001-08-01 | 2003-02-13 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US20030100594A1 (en) | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
| GB0120347D0 (en) | 2001-08-21 | 2001-10-17 | Merck Sharp & Dohme | Therapeutic agents |
| JP2005506979A (ja) | 2001-08-28 | 2005-03-10 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | オキソ置換及びヒドロキシ置換炭化水素のキナルドイル−アミン誘導体を使用するアルツハイマー病の治療方法 |
| EP1465488A4 (de) | 2001-08-30 | 2007-04-18 | Chemocentryx Inc | Arylamine als hemmer der bindung von chemokinen an us28 |
| WO2003022832A1 (en) | 2001-09-05 | 2003-03-20 | Smithkline Beecham P.L.C. | Pyridylfurans and pyrroles as raf kinase inhibitors |
| EP1432703A1 (de) | 2001-09-05 | 2004-06-30 | Smithkline Beecham Plc | Heterocycle-carboxamide derivate als raf kinase inhibitoren |
| JP4210719B2 (ja) | 2001-09-14 | 2009-01-21 | スター・ジャパン株式会社 | 眼用レンズ |
| ME00090B (me) | 2001-09-21 | 2010-10-10 | Bristol Myers Squibb Holdings Ireland | Jedinjenja koja sadrže laktam i njihovi derivati kao inhibitori faktora xa |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| EP1432420B1 (de) | 2001-10-02 | 2011-07-13 | Acadia Pharmaceuticals Inc. | Benzimidazolidinon-derivate als muscarinische mittel |
| DE10149370A1 (de) | 2001-10-06 | 2003-04-10 | Merck Patent Gmbh | Pyrazolderivate |
| US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
| SE0103476D0 (sv) | 2001-10-18 | 2001-10-18 | Markus Heilig | New use |
| EP1439837B1 (de) | 2001-10-23 | 2008-04-09 | Laboratoires Serono SA | Pyrazolidinon-verbindungen als liganden des ep2 und/oder ep4 prostaglandin-rezeptoren |
| GB0130261D0 (en) | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Lactams as tachykinin antagonists |
| EP1468990A4 (de) | 2001-12-21 | 2006-01-04 | Taisho Pharmaceutical Co Ltd | Piperazinderivat |
| IL162874A0 (en) | 2002-01-11 | 2005-11-20 | Sankyo Co | Amino alcohol and phosphonic acid derivatives and pharmaceutical compositions containing the same |
| WO2003068738A1 (en) | 2002-02-11 | 2003-08-21 | Neurocrine Biosciences, Inc. | Pyrrole derivatives as ligands of melanocortin receptors |
| US6995144B2 (en) | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| US6946005B2 (en) | 2002-03-27 | 2005-09-20 | L'oreal S.A. | Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| AU2003220896A1 (en) | 2002-03-28 | 2003-11-10 | Sumitomo Pharmaceuticals Co., Ltd. | Novel heteroaryl compounds |
| WO2003087062A2 (en) | 2002-04-05 | 2003-10-23 | Cadila Healthcare Limited | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| EP1495005A1 (de) | 2002-04-12 | 2005-01-12 | Pfizer Japan Inc. | Pyrazolverbindungen als entzündungshemmende und analgetische wirkstoffe |
| US6794514B2 (en) | 2002-04-12 | 2004-09-21 | Symyx Technologies, Inc. | Ethylene-styrene copolymers and phenol-triazole type complexes, catalysts, and processes for polymerizing |
| WO2003089409A1 (en) | 2002-04-19 | 2003-10-30 | Glaxo Group Limited | Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| CA2483500A1 (en) | 2002-04-26 | 2003-11-06 | Pfizer Products Inc. | Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors |
| JP2005529923A (ja) | 2002-05-13 | 2005-10-06 | イーライ・リリー・アンド・カンパニー | 肥満および糖尿病の治療におけるメラニン凝集ホルモンアンタゴニストとして使用するための多環式化合物 |
| AU2003218176A1 (en) | 2002-06-11 | 2003-12-22 | Bristol-Myers Squibb Company | Asymetric synthesis of amino-pyrrolidinones |
| AU2003243497A1 (en) | 2002-06-12 | 2003-12-31 | Millennium Pharmaceuticals, Inc. | Antagonists of melanin concentrating hormone receptor |
| JP2004020915A (ja) | 2002-06-17 | 2004-01-22 | Konica Minolta Holdings Inc | カラー画像形成方法、デジタル画像作成方法及び資源利用方法 |
| FR2841346B1 (fr) | 2002-06-19 | 2004-11-05 | Eastman Kodak Co | Procede de developpement d'un produit photographique a haut contraste contenant un agent de nucleation de type polyhydrazide |
| AU2003249369A1 (en) | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain amino-substituted monocycles as kinase modulators |
| JP2005531618A (ja) | 2002-07-01 | 2005-10-20 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 重合性、発光性化合物および混合物、発光性ポリマー材料並びにそれらの使用 |
| PL374860A1 (en) | 2002-07-09 | 2005-11-14 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| US6884525B2 (en) | 2002-07-09 | 2005-04-26 | Academia Sinica | Red light emitting materials |
| EP1542997B1 (de) | 2002-07-24 | 2012-02-29 | Dermira (Canada), Inc. | Pyrazolylbenzothiazolderivate und deren verwendung als therapeutische mittel |
| CN1668308A (zh) | 2002-07-29 | 2005-09-14 | 兰贝克赛实验室有限公司 | 作为抗菌剂的噁唑烷酮衍生物 |
| US6923855B2 (en) | 2002-08-06 | 2005-08-02 | Fuji Photo Film Co., Ltd. | Ink, ink-jet-recording method and bis-azo compound |
| AU2003249539A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| BR0313459A (pt) | 2002-08-13 | 2005-06-21 | Warner Lambert Co | Derivados monocìclicos como inibidores de metaloproteinases de matriz |
| TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| US7312208B2 (en) | 2002-08-28 | 2007-12-25 | Asahi Kasei Pharma Corporation | Quaternary ammonium compounds |
| US20070129434A1 (en) | 2002-08-29 | 2007-06-07 | Richard Smith-Carliss | Analgesics and methods of use |
| US6923835B2 (en) | 2002-09-09 | 2005-08-02 | L'oreal S.A. | Bis-para-phenylenediamine derivatives comprising a pyrrolidyl group and use of these derivatives for dyeing keratin fibres |
| EP1542684B1 (de) | 2002-09-18 | 2009-12-02 | Pfizer Products Inc. | Neue pyrazol-verbindungen als hemmer des transformierenden wachstumsfaktors (tgf) |
| JP4631259B2 (ja) | 2002-10-03 | 2011-02-16 | コニカミノルタホールディングス株式会社 | 有機エレクトロルミネッセンス素子及び表示装置 |
| US20040138269A1 (en) | 2002-10-11 | 2004-07-15 | Sugen, Inc. | Substituted pyrroles as kinase inhibitors |
| AU2003287206A1 (en) | 2002-10-23 | 2004-05-13 | Janssen Pharmaceutica, N.V. | Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| WO2004037248A2 (en) | 2002-10-24 | 2004-05-06 | Carex Sa | Modulation of peroxisome proliferator activated receptors activity |
| WO2004037817A1 (ja) | 2002-10-25 | 2004-05-06 | Mitsubishi Pharma Corporation | Ｎ−オキシド化合物 |
| US7351719B2 (en) | 2002-10-31 | 2008-04-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| US7452911B2 (en) | 2002-10-31 | 2008-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| AU2003291024A1 (en) | 2002-11-13 | 2004-06-03 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| EP1567491A4 (de) | 2002-11-21 | 2007-09-19 | New York Blood Ct Inc | Verbindungen zur inhibierung einerhiv-infektion durch blockieren des hiv-eintritts |
| WO2004048341A1 (ja) | 2002-11-28 | 2004-06-10 | Sumitomo Pharmaceuticals Co., Ltd. | 新規ヘテロアリール誘導体 |
| US7183306B2 (en) | 2002-12-02 | 2007-02-27 | Astellas Pharma Inc. | Pyrazole derivatives |
| US7199240B2 (en) | 2002-12-11 | 2007-04-03 | Merck & Co., Inc. | Reductive alkylation of saturated cyclic amines |
| US20040216243A1 (en) | 2002-12-13 | 2004-11-04 | L'oreal | Dye composition comprising a cationic tertiary para-phenylenediamine and a surfactant, processes therefor and uses thereof |
| US7101406B2 (en) | 2002-12-13 | 2006-09-05 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a heterocyclic cationic direct dye, methods and uses |
| US20040250356A1 (en) | 2002-12-13 | 2004-12-16 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses |
| US7271172B2 (en) | 2002-12-13 | 2007-09-18 | Smithkline Beecham Corporation | Pyrrolidine and azetidine compounds as CCR5 antagonists |
| US20040226109A1 (en) | 2002-12-13 | 2004-11-18 | L'oreal | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol, process therefor and use thereof |
| US20040216245A1 (en) | 2002-12-13 | 2004-11-04 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a para-aminophenol, methods and uses |
| US20040231067A1 (en) | 2002-12-13 | 2004-11-25 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses |
| US20040211010A1 (en) | 2002-12-13 | 2004-10-28 | L'oreal | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol ester, processes therefor and uses thereof |
| US20040221400A1 (en) | 2002-12-13 | 2004-11-11 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a monosaccharide or disaccharide, processes and uses |
| US20040216244A1 (en) | 2002-12-13 | 2004-11-04 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and an organic diacid, methods and uses |
| US20040231068A1 (en) | 2002-12-13 | 2004-11-25 | L'oreal | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a cationic polymer, methods and uses |
| US20040205904A1 (en) | 2002-12-13 | 2004-10-21 | L'oreal | Dye composition comprising a cationic tertiary para-phenylenediamine and a vitamin derivative, processes therefor and uses thereof |
| JP4413599B2 (ja) | 2002-12-16 | 2010-02-10 | 株式会社Ｓ・Ｓ・Ｉ | 新規化合物およびそれを含む薬学的組成物 |
| JO2696B1 (en) | 2002-12-23 | 2013-03-03 | شركة جانسين فارماسوتيكا ان. في | Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US20060241157A1 (en) | 2003-01-06 | 2006-10-26 | Conner Scott E | Heterocyclic ppar modulators |
| WO2004063147A1 (en) | 2003-01-10 | 2004-07-29 | Novo Nordisk A/S | Salts and solvates of glucagon antagonists |
| TW200508224A (en) | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| US7338975B2 (en) | 2003-02-12 | 2008-03-04 | Bristol-Myers Squibb Co. | Lactams as modulators of chemokine receptor activity |
| CL2004000234A1 (es) | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| PT1599478E (pt) | 2003-02-26 | 2007-05-31 | Boehringer Ingelheim Pharma | Di-hidropteridinonas, proceso para a sua preparação e a sua utilização como medicamento |
| US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| TWI289141B (en) | 2003-03-11 | 2007-11-01 | Hoffmann La Roche F. Ag. | Quinolinone derivatives and uses thereof |
| CA2519939A1 (en) | 2003-03-26 | 2004-10-14 | Merck & Co., Inc. | Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| EP1620089A4 (de) | 2003-03-26 | 2008-12-24 | Crc For Asthma Ltd | Therapeutische und prophylaktische zusammensetzungen und ihre verwendungen |
| US7132543B2 (en) | 2003-03-28 | 2006-11-07 | L'oreal S.A. | Para-phenylenediamine derivatives containing a disubstituted pyrrolidinyl group bearing a cationic radical, and use of the same for dyeing keratin fibers |
| EP1609799A4 (de) | 2003-04-01 | 2008-10-29 | Taisho Pharmaceutical Co Ltd | Heteroaryl-5-thio-beta-d-glucopyranosidderivate und diese enthaltende mittel gegen diabetes |
| US7439232B2 (en) | 2003-04-01 | 2008-10-21 | Taisho Pharmaceutical Co., Ltd. | Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
| JP2006522164A (ja) | 2003-04-03 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | 代謝調節型グルタミン酸受容体−５のジアリール置換ピラゾール修飾因子 |
| CA2521396A1 (en) | 2003-04-04 | 2004-10-21 | Merck & Co., Inc. | Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| AU2004227854B2 (en) | 2003-04-04 | 2009-07-23 | Merck & Co., Inc. | Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| DE10315573A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituierte Pyrazole |
| DE10315571A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Pyrazolverbindungen |
| DE10315569A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituierte Pyrazolverbindungen |
| DE10315572A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituierte Pyrazole |
| CA2521606A1 (en) | 2003-04-07 | 2004-10-21 | Cortical Pty Ltd. | Novel methods for the treatment of inflammatory diseases |
| US20080214565A1 (en) | 2003-04-07 | 2008-09-04 | Anita Mehta | Oxazolidinone Derivatives as Antimicrobials |
| AR044510A1 (es) | 2003-04-14 | 2005-09-14 | Merck & Co Inc | Procedimiento e intermedios para preparar acidos carboxilicos de pirrolidina |
| AR043850A1 (es) | 2003-04-17 | 2005-08-17 | Bayer Pharmaceuticals Corp | Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos |
| WO2004100868A2 (en) | 2003-04-23 | 2004-11-25 | Abbott Laboratories | Method of treating transplant rejection |
| AU2004236249A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes Of Pharmaceutical Discovery, Llc | Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1B |
| US20040220170A1 (en) | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| EP1620091B1 (de) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Glutaminylcyclase-hemmer |
| US8338120B2 (en) | 2003-05-05 | 2012-12-25 | Probiodrug Ag | Method of treating inflammation with glutaminyl cyclase inhibitors |
| WO2004099199A1 (en) | 2003-05-06 | 2004-11-18 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| BRPI0410349A (pt) | 2003-05-12 | 2006-05-30 | Pfizer Prod Inc | inibidores de benzamida do receptor p2x7 |
| CA2525547C (en) | 2003-05-14 | 2012-07-03 | Torreypines Therapeutics, Inc. | Compounds and uses thereof in modulating amyloid beta |
| US7220745B2 (en) | 2003-05-15 | 2007-05-22 | Rigel Pharmaceuticals | Heterocyclic compounds useful to treat HCV |
| BRPI0411221A (pt) | 2003-06-11 | 2006-07-18 | Sankyo Co | composto, medicamento, métodos para inibir a produção de citocinas inflamatórias, e para a prevenção ou tratamento de doenças associadas com citocinas inflamatórias, método para o tratamento ou alìvio de febre, dor e/ou inflamação e, métodos para a prevenção ou tratamento de artrite reumatóide, de osteoartrite, de doença septicêmica, psorìase, doença de crohn, colite ulcerativa, diabete melito ou, hepatite |
| JP2005035983A (ja) | 2003-06-25 | 2005-02-10 | Taisho Pharmaceut Co Ltd | 不安神経症又はうつ症治療薬 |
| GB0315111D0 (en) | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
| WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
| CA2530679A1 (en) | 2003-06-30 | 2005-04-07 | Hif Bio, Inc. | Compounds for treating angiogenesis |
| JP2005046141A (ja) | 2003-07-11 | 2005-02-24 | Sankyo Co Ltd | リン酸エステルの製造方法 |
| EP1651633A1 (de) | 2003-07-25 | 2006-05-03 | Novartis AG | Substituierte lactame und deren verwendung als antikrebsmittel |
| DE10336202A1 (de) | 2003-08-07 | 2005-03-03 | Wella Ag | Mittel und Verfahren zur Färbung keratinischer Fasern |
| US20050043392A1 (en) | 2003-08-21 | 2005-02-24 | Carter Percy H. | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7863317B2 (en) | 2003-08-21 | 2011-01-04 | Bristol-Myers Squibb Company | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7375090B2 (en) | 2003-08-26 | 2008-05-20 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof |
| WO2005023809A1 (en) | 2003-09-10 | 2005-03-17 | Virochem Pharma Inc. | Spiro compounds and methods for the modulation of chemokine receptor activity |
| WO2005030128A2 (en) | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Pyrazole modulators of metabotropic glutamate receptors |
| EP1675585A2 (de) | 2003-10-17 | 2006-07-05 | Tanabe Seiyaku Co., Ltd. | Kalzium-aktivierter k kanalöffner mit grosser leitfähigkeit |
| WO2005041951A2 (en) | 2003-10-28 | 2005-05-12 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives for use as antiviral agents |
| GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| FR2862647B1 (fr) | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
| WO2005065681A1 (en) | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
| US20070191336A1 (en) | 2003-12-24 | 2007-08-16 | Flynn Daniel L | Anti-inflammatory medicaments |
| US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| CN1964957A (zh) | 2004-01-26 | 2007-05-16 | 南阿拉巴马大学 | 基于阴离子甜味剂的离子液体及其使用方法 |
| US20050257329A1 (en) | 2004-01-28 | 2005-11-24 | Gregory Plos | Composition for dyeing keratin fibers, comprising at least one alcohol oxidase and at least one cationic oxidation base, and process using this composition |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| CN100432075C (zh) | 2004-02-04 | 2008-11-12 | 神经研究公司 | 作为烟碱样乙酰胆碱受体配体的二氮杂双环芳基衍生物 |
| CN1918131B (zh) | 2004-02-05 | 2011-05-04 | 前体生物药物股份公司 | 谷氨酰胺酰基环化酶抑制剂 |
| EP1720828A2 (de) | 2004-02-06 | 2006-11-15 | Insight Biopharmaceuticals Ltd | Heparanaseinhibitoren und anwendungen davon |
| KR20070027503A (ko) | 2004-02-18 | 2007-03-09 | 아스트라제네카 아베 | 트리아졸 화합물 및 대사성 글루타메이트 수용체길항제로서 이들의 용도 |
| US20070185106A1 (en) | 2004-02-20 | 2007-08-09 | Astrazeneca Ab | Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
| WO2005081972A2 (en) | 2004-02-22 | 2005-09-09 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Maleiimide anti-tumor phosphatase inhibitors |
| US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
| EP1724271A4 (de) | 2004-02-26 | 2013-01-23 | Kyowa Hakko Kirin Co Ltd | Präventives und/oder therapeutisches mittel gegen neutrophile entzündungskrankheit |
| MX341474B (es) | 2004-03-03 | 2016-08-19 | Takeda Gmbh | Nuevas hidroxi-6-heteroarilfenantridinas y su uso como inhibidores de la fosfodiesterasa tipo 4 ( pde4). |
| US7605176B2 (en) | 2004-03-06 | 2009-10-20 | Boehringer Ingelheim International Gmbh | β-ketoamide compounds with MCH antagonistic activity |
| US7786165B2 (en) | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| WO2005090297A1 (en) | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Sulphonamide derivatives |
| US7378532B2 (en) | 2004-03-26 | 2008-05-27 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Fused pyrazolyl compound |
| US8273743B2 (en) | 2004-04-30 | 2012-09-25 | Curis, Inc. | Quinoxaline inhibitors of the hedgehog signalling |
| FR2870729B1 (fr) | 2004-05-28 | 2006-07-14 | Oreal | Composition pour le traitement de fibres keratiniques comprenant un compose polycarboxylique particulier et une base d'oxydation cationique ou non, procede et dispositif la mettant en oeuvre |
| DE102004028241B4 (de) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| US7288122B2 (en) | 2004-06-23 | 2007-10-30 | L'oreal S.A. | Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| FR2872163B1 (fr) | 2004-06-23 | 2006-08-04 | Oreal | Composes diazoiques cationiques particuliers, compositions les comprenant a titre de colorant direct, procede de coloration de fibres keratiniques et dispositif |
| EP1768975A2 (de) | 2004-06-25 | 2007-04-04 | Pfizer Products Inc. | Pyridylpiperazine zur behandlung von erkrankungen des zns |
| WO2006020277A2 (en) | 2004-07-19 | 2006-02-23 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| JP2006036730A (ja) | 2004-07-30 | 2006-02-09 | Sumitomo Pharmaceut Co Ltd | 新規ピロール誘導体 |
| US20070270471A1 (en) | 2004-08-09 | 2007-11-22 | Glaxo Group Limited | Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
| US20060223866A1 (en) | 2004-08-13 | 2006-10-05 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| AU2005272627A1 (en) | 2004-08-13 | 2006-02-23 | Amgen Inc. | Substituted benzofused heterocycles |
| EP1781595A1 (de) | 2004-08-13 | 2007-05-09 | Praecis Pharmaceuticals Inc. | Verfahren und zusammensetzungen zur modulation von sphingosin-1-phosphat-rezeptoraktivität |
| EP1781283A2 (de) | 2004-08-13 | 2007-05-09 | Merck & Co., Inc. | Hemmung des freiwilligen ethanolkonsums mit nicht-peptidyl-melanocortin-4-rezeptoragonisten |
| WO2006023460A2 (en) | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| EP1630163A1 (de) | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| WO2006021462A1 (en) | 2004-08-27 | 2006-03-02 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| EP1634872A1 (de) | 2004-08-27 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Pyrazolderivate als Inhibitoren von Sigmarezeptoren |
| WO2006026305A1 (en) | 2004-08-31 | 2006-03-09 | Biogen Idec Ma Inc | Pyrimidinylpyrazoles as tgf-beta inhibitors |
| KR20070106678A (ko) | 2004-09-13 | 2007-11-05 | 바이엘 크롭사이언스 아게 | Ｎ-(치환된 아릴메틸)-4-치환-4-(이치환된 메틸)피페리딘및 중간체의 제조방법 |
| MX2007002886A (es) | 2004-09-13 | 2007-05-16 | Ono Pharmaceutical Co | Derivado heterociclico que contiene nitrogeno y un farmaco que contiene el mismo como el ingrediente activo. |
| BRPI0515482A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| AU2005286648A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CN101083992A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物 |
| JP5094398B2 (ja) | 2004-09-20 | 2012-12-12 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環式誘導体およびステアロイル−ＣｏＡデサチュラーゼのメディエータとしてのそれらの使用 |
| JP2006117651A (ja) | 2004-09-27 | 2006-05-11 | Taisho Pharmaceut Co Ltd | Ｓｇｌｔ２の活性阻害剤 |
| US7410506B2 (en) | 2004-10-14 | 2008-08-12 | L'oreal S.A. | Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof |
| CA2584248A1 (en) | 2004-10-15 | 2006-04-27 | Biogen Idec Ma Inc. | Methods of treating vascular injuries |
| JP2008519078A (ja) | 2004-11-04 | 2008-06-05 | ニューロゲン コーポレイション | Ｃｂ１拮抗薬としてのアリールアルキル尿素類 |
| US20080004269A1 (en) | 2004-11-04 | 2008-01-03 | Yuelian Xu | Pyrazolylmethy Heteroaryl Derivatives |
| EP1655359A1 (de) | 2004-11-06 | 2006-05-10 | Covion Organic Semiconductors GmbH | Organische Elektrolumineszenzvorrichtung |
| US20080051418A1 (en) | 2004-11-26 | 2008-02-28 | Tsuyoshi Maekawa | Arylalkanoic Acid Derivative |
| FR2878528B1 (fr) | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
| AU2005312048B2 (en) | 2004-11-30 | 2012-08-02 | Amgen Inc. | Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| GB0426342D0 (en) | 2004-12-01 | 2005-01-05 | Eastman Kodak Co | Coupler capable of releasing development accelerator |
| DE102004058061A1 (de) | 2004-12-02 | 2006-06-08 | Wella Ag | Nichtionische Azomethine enthaltende oxidative Färbemittel |
| CA2590737A1 (en) | 2004-12-09 | 2006-06-15 | Virochem Pharma Inc. | Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| JP2006188504A (ja) | 2004-12-10 | 2006-07-20 | Sankyo Co Ltd | 環状３級アミン化合物を含有する医薬組成物 |
| WO2006081034A2 (en) | 2004-12-23 | 2006-08-03 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| JP2006182668A (ja) | 2004-12-27 | 2006-07-13 | Dainippon Sumitomo Pharma Co Ltd | 高脂質症、動脈硬化、および／またはメタボリックシンドローム治療剤 |
| WO2006071875A1 (en) | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| JP4302762B2 (ja) | 2005-01-07 | 2009-07-29 | ファイザー・プロダクツ・インク | 複素環式芳香族キノリン化合物およびｐｄｅ１０阻害剤としてのその使用 |
| US8853205B2 (en) | 2005-01-10 | 2014-10-07 | University Of Connecticut | Heteropyrrole analogs acting on cannabinoid receptors |
| GB0500435D0 (en) | 2005-01-10 | 2005-02-16 | Novartis Ag | Organic compounds |
| JP2008526887A (ja) | 2005-01-10 | 2008-07-24 | ユニバーシティ オブ コネチカット | カンナビノイド受容体に作用する新規なヘテロピロール類似体 |
| WO2006078891A2 (en) | 2005-01-21 | 2006-07-27 | Neurogen Corporation | Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| US20080287516A1 (en) | 2005-01-28 | 2008-11-20 | Irm Llc | Phenyl-Substituted Pyrrolidones |
| FR2881426B1 (fr) | 2005-02-03 | 2007-03-30 | Aventis Pharma Sa | Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation |
| US8715521B2 (en) | 2005-02-04 | 2014-05-06 | E I Du Pont De Nemours And Company | Absorption cycle utilizing ionic liquid as working fluid |
| FR2881742B1 (fr) | 2005-02-10 | 2007-09-07 | Aventis Pharma Sa | Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation |
| JP4652079B2 (ja) | 2005-02-15 | 2011-03-16 | 花王株式会社 | ２，２−二置換エチレンジアミン誘導体の製造方法 |
| WO2006091862A2 (en) | 2005-02-24 | 2006-08-31 | Kemia, Inc. | Cytokine inhibitors and their use in therapy |
| JP4677359B2 (ja) | 2005-03-23 | 2011-04-27 | アフトン・ケミカル・コーポレーション | 潤滑組成物 |
| US20090264650A1 (en) | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
| EP1710237A1 (de) | 2005-04-08 | 2006-10-11 | Bayer CropScience S.A. | Neue Heterocyclylbenzamid-Derivate |
| JP2006316054A (ja) | 2005-04-15 | 2006-11-24 | Tanabe Seiyaku Co Ltd | 高コンダクタンス型カルシウム感受性ｋチャネル開口薬 |
| AU2006240789B2 (en) | 2005-04-22 | 2010-03-04 | Daiichi Sankyo Company, Limited | Heterocyclic compound |
| MX2007012907A (es) | 2005-04-28 | 2008-03-14 | Boehringer Ingelheim Int | Nuevos compuestos para el tratamiento de enfermedades inflamatorias. |
| PL2444085T3 (pl) | 2005-05-13 | 2015-07-31 | Univ California | Związki diarylohydantoinowe jako antagoniści receptora androgenów do leczenia raka |
| GB0510141D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| CA2608542A1 (en) | 2005-05-18 | 2006-11-23 | E.I. Dupont De Nemours And Company | Hybrid vapor compression-absorption cycle |
| EP1728790A1 (de) | 2005-06-01 | 2006-12-06 | Max-Delbrück-Centrum Für Molekulare Medizin | Shp-2-Inhibitoren, Arzneimittel, die sie enthalten sowie deren Verwendung zur Behandlung von Phosphatasen-vermittelten Krankheiten |
| DE102005026231A1 (de) | 2005-06-07 | 2006-12-14 | Origenis Ag | Peptid-Deformylase (PDF) Inhibitoren 3 |
| ES2569881T3 (es) | 2005-06-08 | 2016-05-12 | The University Of North Carolina At Chapel Hill | Procedimientos para facilitar la supervivencia de células neuronales usando miméticos de neurotrofina BDNF peptídicos y no peptídicos |
| US7709516B2 (en) | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
| AU2006261845C1 (en) | 2005-06-27 | 2013-05-16 | Exelixis Patent Company Llc | Imidazole based LXR modulators |
| US8039507B2 (en) | 2005-06-29 | 2011-10-18 | Allergan, Inc. | Therapeutic substituted gamma lactams |
| JP2009501156A (ja) | 2005-06-29 | 2009-01-15 | ケモセントリックス，インコーポレイティド | 置換ｎ−シンナミルベンズアミド |
| MX2007016508A (es) | 2005-06-30 | 2008-03-04 | Prosidion Ltd | Agonistas del receptor acoplado a la proteina g. |
| US20090221644A1 (en) | 2005-06-30 | 2009-09-03 | Stuart Edward Bradley | Gpcr Agonists |
| ES2326723B1 (es) | 2005-07-15 | 2010-05-11 | Laboratorios Del Dr. Esteve, S.A. | Uso de compuestos de pirazol sustituidos y combinaciones de los mismos para el tratamiento del sindrome metabolico. |
| US20090118296A1 (en) | 2005-07-20 | 2009-05-07 | Merck Frosst Canada Ltd. | Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase |
| FR2889189A1 (fr) | 2005-07-28 | 2007-02-02 | Cerep Sa | Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1 |
| FR2889191A1 (fr) | 2005-07-28 | 2007-02-02 | Cerep Sa | Composes derives de 5-benzylidene imidazolidine 2,4-dione et leur utilisation en tant qu'antagonistes de mchr-1 |
| JP2007063261A (ja) | 2005-08-01 | 2007-03-15 | Kyowa Hakko Kogyo Co Ltd | Ｘ線照射による肺障害の予防及び／または治療剤 |
| US20080234280A1 (en) | 2005-08-01 | 2008-09-25 | Mcmurray Gordon | Use of Mc4 Receptor Agonist Compounds |
| EP1922068A4 (de) | 2005-08-16 | 2010-08-11 | Icagen Inc | Inhibitoren von spannungsgesteuerten natriumkanälen |
| WO2007023880A1 (ja) | 2005-08-24 | 2007-03-01 | Kyowa Hakko Kogyo Co., Ltd. | ケモカイン産生阻害剤 |
| AR058054A1 (es) | 2005-09-22 | 2008-01-23 | Du Pont | Utilizacion de liquidos ionicos para la separacion de hidrofluorocarburos |
| EP1940914B1 (de) | 2005-09-22 | 2009-05-13 | E.I. Du Pont De Nemours And Company | Herstellung von polytrimethylenetherglykol und copolymeren davon |
| US7544813B2 (en) | 2005-09-22 | 2009-06-09 | E.I. Du Pont De Nemours And Company | Ionic liquids |
| JP5185517B2 (ja) | 2005-09-22 | 2013-04-17 | 三菱製紙株式会社 | 光電変換材料、半導体電極並びにそれを用いた光電変換素子 |
| US7528287B2 (en) | 2005-09-22 | 2009-05-05 | E.I. Du Pont De Nemours And Company | Preparation of poly(tetramethylene) glycol |
| TW200720365A (en) | 2005-10-12 | 2007-06-01 | Clariant Int Ltd | Barbituric acid based azo metal complex dyes and their use in optical layers for optical data recording |
| WO2007047496A2 (en) | 2005-10-18 | 2007-04-26 | Merck & Co., Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| US20070100181A1 (en) | 2005-10-27 | 2007-05-03 | Harmer Mark A | Olefin isomerization |
| US20070100184A1 (en) | 2005-10-27 | 2007-05-03 | Harmer Mark A | Alkylation of aromatic compounds |
| TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
| US20090012148A1 (en) | 2005-11-01 | 2009-01-08 | Maxfield Frederick R | Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| TW200734304A (en) | 2005-11-08 | 2007-09-16 | Astellas Pharma Inc | Benzene derivative or salt thereof |
| WO2007059359A2 (en) | 2005-11-21 | 2007-05-24 | Biogen Idec Ma Inc. | Substituted pyrazalones |
| WO2007062459A1 (en) | 2005-11-29 | 2007-06-07 | Cytopia Research Pty Ltd | Selective kinase inhibitors based on pyridine scaffold |
| WO2007067836A2 (en) * | 2005-12-05 | 2007-06-14 | Boehringer Ingelheim International Gmbh | Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| US8506839B2 (en) | 2005-12-14 | 2013-08-13 | E I Du Pont De Nemours And Company | Absorption cycle utilizing ionic liquids and water as working fluids |
| WO2007076231A2 (en) | 2005-12-16 | 2007-07-05 | Symyx Technologies, Inc. | Bridged phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
| TWI403320B (zh) | 2005-12-16 | 2013-08-01 | Infinity Discovery Inc | 用於抑制ｂｃｌ蛋白和結合夥伴間之交互作用的化合物及方法 |
| WO2007071023A1 (en) | 2005-12-20 | 2007-06-28 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AU2006331882A1 (en) | 2005-12-21 | 2007-07-05 | Schering Corporation | Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists |
| EP2316829A1 (de) | 2005-12-21 | 2011-05-04 | Vertex Pharmaceuticals Incorporated | Heterocyclische Derivate als Ionenkanalmodulatoren |
| WO2007076104A1 (en) | 2005-12-23 | 2007-07-05 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| FR2896504B1 (fr) | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
| JP2009524683A (ja) | 2006-01-25 | 2009-07-02 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のためのビニル−フェニル誘導体 |
| WO2007085954A2 (en) | 2006-01-27 | 2007-08-02 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
| DE102006005103A1 (de) | 2006-02-04 | 2007-08-09 | Merck Patent Gmbh | Oxonium- und Sulfoniumsalze |
| US7772266B2 (en) | 2006-02-15 | 2010-08-10 | Dendreon Corporation | Small-molecule modulators of TRP-P8 activity |
| RS53088B (en) | 2006-02-15 | 2014-06-30 | Dendreon Corporation | LOW MOLECULAR TRP-P8 ACTIVITY MODULATORS |
| US7868177B2 (en) | 2006-02-24 | 2011-01-11 | Amgen Inc. | Multi-cyclic compounds and method of use |
| EP1994032A1 (de) | 2006-03-01 | 2008-11-26 | Laboratorios del Dr. Esteve S.A. | Pyrazolderivate als inhibitoren des sigma-rezeptors |
| JP4851546B2 (ja) | 2006-03-10 | 2012-01-11 | ジェンリン ディスカバリー | 肥満治療に有用なカンナビノイド受容体アンタゴニスト／インバースアゴニスト |
| GB0605120D0 (en) | 2006-03-14 | 2006-04-26 | Novartis Ag | Organic Compounds |
| JP2009530274A (ja) | 2006-03-15 | 2009-08-27 | ワイス | ヒスタミン−３アンタゴニストとしてのｎ−置換−アザシクリルアミン化合物 |
| WO2007109456A2 (en) | 2006-03-16 | 2007-09-27 | Pharmacopeia, Inc. | Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists |
| WO2007107543A1 (en) | 2006-03-22 | 2007-09-27 | Janssen Pharmaceutica N.V. | Inhibitors of the interaction between mdm2 and p53 |
| KR101456722B1 (ko) | 2006-03-29 | 2014-10-31 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 디아릴티오히단토인 화합물 |
| GB0606804D0 (en) | 2006-04-04 | 2006-05-17 | Novartis Ag | Organic Compounds |
| GB0606805D0 (en) | 2006-04-04 | 2006-05-17 | Novartis Ag | Organic compounds |
| US20070238718A1 (en) | 2006-04-06 | 2007-10-11 | Matthias Grauert | Thiazolyl-dihydro-indazole |
| CN101460506A (zh) | 2006-04-06 | 2009-06-17 | 贝林格尔.英格海姆国际有限公司 | 用作蛋白激酶抑制剂的噻唑基-二氢-吲唑衍生物 |
| US7435833B2 (en) | 2006-04-07 | 2008-10-14 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| US7875636B2 (en) * | 2006-04-12 | 2011-01-25 | Merck Sharp & Dohme Corp. | Pyridyl amide T-type calcium channel antagonists |
| EP1849781A1 (de) | 2006-04-28 | 2007-10-31 | Laboratorios del Dr. Esteve S.A. | 3-Amino-4-hydroxy pyrrolidine Derivate, Methode zur Herstellung und Gebrauch als Medikamente |
| CA2650976A1 (en) | 2006-05-02 | 2007-11-15 | Pfizer Products Inc. | Bicyclic heteroaryl compounds as pde10 inhibitors |
| JP2009537571A (ja) | 2006-05-22 | 2009-10-29 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしての環状アミン誘導体 |
| TW200808649A (en) | 2006-05-31 | 2008-02-16 | Du Pont | Process for purifying perfluorinated products |
| WO2007143051A2 (en) | 2006-05-31 | 2007-12-13 | E. I. Du Pont De Nemours And Company | Vapor compression utilizing ionic liquid as compressor lubricant |
| CA2691214A1 (en) | 2006-06-09 | 2007-12-21 | Kemia, Inc. | Therapy using cytokine inhibitors |
| US8168641B2 (en) | 2006-06-12 | 2012-05-01 | Schering Corporation | Aspartyl protease inhibitors |
| JP2009539885A (ja) | 2006-06-13 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイルコエンザイムａデルタ−９デサチュラーゼの阻害剤としてのアザシクロペンタン誘導体 |
| DE102006028507A1 (de) | 2006-06-21 | 2007-12-27 | *Acri.Tec AG Gesellschaft für ophthalmologische Produkte | Ophthalmologische Zusammensetzung und ihre Verwendung |
| CA2656067C (en) | 2006-06-23 | 2014-08-12 | Radius Health, Inc. | Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| CA2647601A1 (en) | 2006-06-27 | 2008-01-03 | Abbott Laboratories | Pyrrole derivatives and their methods of use |
| ITMI20061279A1 (it) | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
| US8115005B2 (en) | 2006-08-04 | 2012-02-14 | Decode Genetics Ehf. | Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation |
| WO2008024953A2 (en) | 2006-08-25 | 2008-02-28 | Brandeis University | Transition metal-catalyzed alkylation of c-h bonds with organoboron reagents |
| DE102006040915A1 (de) | 2006-08-26 | 2008-03-20 | Abbott Gmbh & Co. Kg | Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung |
| US20080064729A1 (en) | 2006-09-07 | 2008-03-13 | Millennium Pharmaceuticals, Inc. | Phenethylamide derivatives with kinase inhibitory activity |
| WO2008031034A2 (en) | 2006-09-07 | 2008-03-13 | Myriad Genetics, Inc. | Therapeutic compounds for diseases and disorders |
| WO2008036678A2 (en) | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US8354432B2 (en) | 2006-10-04 | 2013-01-15 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| CA2675511A1 (en) | 2006-10-10 | 2008-04-17 | Amgen Inc. | N-aryl pyrazole compounds for use against diabetes |
| JP2008120794A (ja) | 2006-10-16 | 2008-05-29 | Daiichi Sankyo Co Ltd | ヘテロ環化合物を含有する医薬組成物 |
| WO2008048914A1 (en) | 2006-10-17 | 2008-04-24 | Boehringer Ingelheim International Gmbh | Polycyclic compounds which modulate the cb2 receptor |
| EP2076509A4 (de) | 2006-10-20 | 2011-02-16 | Merck Frosst Canada Ltd | Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase |
| DE102006050512A1 (de) | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| JP5049552B2 (ja) | 2006-10-30 | 2012-10-17 | キヤノン株式会社 | 現像ローラ、プロセスカートリッジ及び画像形成装置 |
| GB0621607D0 (en) | 2006-10-31 | 2006-12-06 | Chroma Therapeutics Ltd | Inhibitors of c-Met |
| EP2394647A1 (de) | 2006-11-02 | 2011-12-14 | Aestus Therapeutics, Inc. | Verfahren zur Behandlung neuropathischer Schmerzen mittels Modulation von Glykogenolyse- oder Glykolyse-Wegen |
| EP2086914A1 (de) | 2006-11-08 | 2009-08-12 | E.I. Du Pont De Nemours And Company | Verfahren zur trennung von tetrafluorethylen von kohlendioxid mittels ionischer flüssigkeiten |
| WO2008062276A2 (en) | 2006-11-20 | 2008-05-29 | Glenmark Pharmaceuticals S.A. | Acetylene derivatives as stearoyl coa desaturase inhibitors |
| FR2908766B1 (fr) | 2006-11-20 | 2009-01-09 | Sanofi Aventis Sa | Derives de pyrrole,leur preparation et leur utilisation en therapeutique. |
| WO2008064318A2 (en) | 2006-11-22 | 2008-05-29 | University Of Medicine And Dentistry Of New Jersey | Peripheral opioid receptor active compounds |
| WO2008064317A1 (en) | 2006-11-22 | 2008-05-29 | University Of Medicine And Dentistry Of New Jersey | Lipophilic opioid receptor active compounds |
| AU2007333194A1 (en) | 2006-12-08 | 2008-06-19 | Exelixis, Inc. | LXR and FXR modulators |
| TW200831080A (en) | 2006-12-15 | 2008-08-01 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| MX2009006751A (es) | 2006-12-21 | 2009-06-30 | Abbott Lab | Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato. |
| US8217027B2 (en) | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| US20080153697A1 (en) | 2006-12-22 | 2008-06-26 | E. I. Dupont De Nemours And Company | Mixtures of ammonia and ionic liquids |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| NZ577719A (en) | 2006-12-29 | 2012-06-29 | Abbott Gmbh & Co Kg | Pyrazol-1-yl-aryl amides and their analogues and their pharmaceutical uses |
| EP1938686A1 (de) | 2006-12-29 | 2008-07-02 | Bayer CropScience AG | Substituierte 1-(3-Pyridinyl)pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| EP3124490A1 (de) | 2007-01-31 | 2017-02-01 | Sigma-Aldrich Co. LLC | Hochstabile polyionische flüssigsalze |
| WO2008106202A1 (en) | 2007-02-27 | 2008-09-04 | Housey Gerard M | Theramutein modulators |
| US8338437B2 (en) | 2007-02-28 | 2012-12-25 | Methylgene Inc. | Amines as small molecule inhibitors |
| JP2010520294A (ja) | 2007-03-07 | 2010-06-10 | アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド | 複素環式部分を含有するメタロプロテアーゼ阻害剤 |
| US7947770B2 (en) | 2007-03-07 | 2011-05-24 | E. I. Du Pont De Nemours And Company | Flame retardant polycarbonate compositions |
| JP5126570B2 (ja) | 2007-03-12 | 2013-01-23 | 株式会社デンソー | リチウム二次電池の製造方法 |
| AU2008225766B2 (en) | 2007-03-15 | 2012-06-07 | Novartis Ag | Organic compounds and their uses |
| AR065785A1 (es) | 2007-03-19 | 2009-07-01 | Xenon Pharmaceuticals Inc | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro |
| WO2008124087A1 (en) | 2007-04-03 | 2008-10-16 | E. I. Du Pont De Nemours And Company | Heat transfer systems using mixtures of polyols and ionic liquids |
| WO2008131148A1 (en) | 2007-04-19 | 2008-10-30 | The Trustees Of The University Of Pennsylvania | Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques |
| CA2684949A1 (en) | 2007-04-20 | 2008-10-30 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| US20110189167A1 (en) | 2007-04-20 | 2011-08-04 | Flynn Daniel L | Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases |
| US9266830B2 (en) | 2007-04-23 | 2016-02-23 | Bayer Intellectual Property Gmbh | Pesticidal arylpyrrolidines |
| JP2008266230A (ja) | 2007-04-23 | 2008-11-06 | Bayer Cropscience Ag | 殺虫性アリールピロリジン類 |
| JP2010116389A (ja) | 2008-10-17 | 2010-05-27 | Bayer Cropscience Ag | 殺虫性アリールピロリジン類 |
| CA2685029A1 (en) | 2007-04-26 | 2008-11-06 | Avalon Pharmaceuticals | Multi-ring compounds and uses thereof |
| TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| WO2008137102A2 (en) | 2007-05-04 | 2008-11-13 | Torreypines Therapeutics, Inc. | Methods of modulating amyloid beta and compounds useful therefor |
| US8075777B2 (en) | 2007-05-16 | 2011-12-13 | E. I. Du Pont De Nemours And Company | Process for the separation of diastereomers |
| EP2148877A2 (de) | 2007-05-18 | 2010-02-03 | Bayer Schering Pharma AG | Hemmer des hypoxie-induzierten faktors (hif) zur behandlung hyperproliferativer und mit angiogenese zusammenhängender erkrankungen |
| US7964760B2 (en) | 2007-05-25 | 2011-06-21 | E.I. Du Pont De Nemours And Company | Process for the separation of fluorocarbons using ionic liquids |
| CA2687931C (en) | 2007-05-31 | 2016-05-24 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists and uses thereof |
| WO2008151253A1 (en) | 2007-06-04 | 2008-12-11 | Threshold Pharmaceuticals, Inc. | Hypoxia activated prodrugs of antineoplastic agents |
| US8299115B2 (en) | 2007-06-08 | 2012-10-30 | Debnath Bhuniya | Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| US8436028B2 (en) | 2007-06-20 | 2013-05-07 | Merck Sharp & Dohme Corp | CETP inhibitors derived from benzoxazole arylamides |
| EP2176249A2 (de) | 2007-07-02 | 2010-04-21 | Boehringer Ingelheim International GmbH | Neue chemische verbindungen |
| WO2009009041A2 (en) | 2007-07-06 | 2009-01-15 | Kinex Pharmaceuticals, Llc | Compositions and methods for modulating a kinase cascade |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二（芳胺基）芳基化合物 |
| EP2183221A1 (de) | 2007-07-12 | 2010-05-12 | Crystax Pharmaceuticals S.L. | Neue verbindungen als hsp90-inhibitoren |
| WO2009012262A1 (en) | 2007-07-16 | 2009-01-22 | The Regents Of The University Of California | Protein kinase modulating compounds and methods for making and using them |
| EP2173728A2 (de) | 2007-07-17 | 2010-04-14 | Amgen Inc. | Heterocyclische pkb-modulatoren |
| WO2009012647A1 (fr) | 2007-07-20 | 2009-01-29 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Procédés de préparation de dérivés de quinazoline et leurs utilisations pharmaceutiques |
| JP5736098B2 (ja) | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
| ES2545121T3 (es) | 2007-08-21 | 2015-09-08 | Senomyx, Inc. | Compuestos que inhiben (bloquean) el sabor amargo en composiciones, y uso de los mismos |
| DE102007040243A1 (de) | 2007-08-25 | 2009-02-26 | Universität des Saarlandes | 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen |
| WO2009026658A1 (en) | 2007-08-29 | 2009-03-05 | The University Of Sydney | Ppar agonists |
| KR100952965B1 (ko) | 2007-08-30 | 2010-04-16 | 제일모직주식회사 | 액정배향제, 및 이를 이용하여 제조된 액정배향막 |
| CN101835741A (zh) | 2007-09-04 | 2010-09-15 | 比奥里波克斯公司 | 用于炎症治疗的双芳香族化合物 |
| JP2010538083A (ja) | 2007-09-05 | 2010-12-09 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | ２−ブタノールからジブチルエーテルを形成する方法 |
| US20100174120A1 (en) | 2007-09-05 | 2010-07-08 | E.I. Du Pont De Nemours And Company | Processes for making dibutyl ethers from isobutanol |
| JP2010538082A (ja) | 2007-09-05 | 2010-12-09 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | アルコールからジアルキルエーテルを形成する方法 |
| CA2698341A1 (en) | 2007-09-06 | 2009-03-12 | Schering Corporation | Gamma secretase modulators |
| US8133904B2 (en) | 2007-09-07 | 2012-03-13 | Jenrin Discovery, Inc. | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| TW200920357A (en) | 2007-09-10 | 2009-05-16 | Curis Inc | HSP90 inhibitors containing a zinc binding moiety |
| TW200924777A (en) | 2007-09-14 | 2009-06-16 | Methylgene Inc | Combination therapy |
| DE102007044032A1 (de) | 2007-09-14 | 2009-03-19 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| AR068509A1 (es) | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
| US7994174B2 (en) | 2007-09-19 | 2011-08-09 | Vertex Pharmaceuticals Incorporated | Pyridyl sulfonamides as modulators of ion channels |
| US20100200799A1 (en) | 2007-09-28 | 2010-08-12 | E.I. Du Pont De Nemours And Company | Ionic liquid stabilizer compositions |
| WO2009040659A2 (en) | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| CA2700974A1 (en) | 2007-10-04 | 2009-04-09 | Merck Sharp & Dohme Corp. | Substituted aryl sulfone derivatives as calcium channel blockers |
| US8188302B2 (en) | 2007-10-12 | 2012-05-29 | The Board Of Trustees Of The University Of Illinois | Hydroamination of alkenes |
| US8188080B2 (en) | 2007-10-17 | 2012-05-29 | Sanford-Burnham Medical Research Institute | VHR protein tyrosine phosphatase inhibitors, compositions and methods of use |
| CN101910133A (zh) | 2007-10-24 | 2010-12-08 | 默沙东公司 | 杂环苯基酰胺t-型钙通道拮抗剂 |
| AR069005A1 (es) | 2007-10-25 | 2009-12-23 | Speedel Experimenta Ag | Piperidinas 4,4-disustituidas |
| JP2011503022A (ja) | 2007-11-02 | 2011-01-27 | ノバルティス アーゲー | レニン阻害剤としての４，４−二置換ピペリジン |
| US20090118276A1 (en) | 2007-11-02 | 2009-05-07 | Wyeth | Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| US9539778B2 (en) | 2007-11-28 | 2017-01-10 | The Goodyear Tire & Rubber Company | Pneumatic tire and a process to retread a tire |
| US7973051B2 (en) | 2007-11-30 | 2011-07-05 | Hoffman-La Roche Inc. | Aminothiazoles as FBPase inhibitors for diabetes |
| KR100913605B1 (ko) | 2007-12-07 | 2009-08-26 | 제일모직주식회사 | 액정 광배향제, 이를 포함하는 액정 광배향막, 및 이를포함하는 액정 표시 장치 |
| JP2011506348A (ja) | 2007-12-11 | 2011-03-03 | メルク フロスト カナダ リミテツド | ステアロイル−補酵素ａデルタ−９デサチュラーゼの阻害剤としての新規な複素環式芳香族化合物 |
| WO2009079009A1 (en) | 2007-12-19 | 2009-06-25 | Yangbo Feng | Anilides and analogs as rho kinase inhibitors |
| AU2008339570B2 (en) | 2007-12-20 | 2012-04-12 | Astrazeneca Ab | Carbamoyl compounds as DGAT1 inhibitors 190 |
| RU2474581C2 (ru) | 2007-12-26 | 2013-02-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ получения замещенных гетероциклом производных пиридина |
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
| WO2009097141A1 (en) | 2008-01-31 | 2009-08-06 | Joslin Diabetes Center | Methods for treatment of kallikrein-related disorders |
| US8980643B2 (en) | 2008-02-15 | 2015-03-17 | Sigma-Aldrich Co., Llc | Dicationic liquid salts and methods of use thereof |
| CA2715290A1 (en) | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US20110027264A1 (en) | 2008-02-29 | 2011-02-03 | Xianhai Huang | Gamma secretase modulators for the treatment of alzheimer's disease |
| WO2009120872A2 (en) | 2008-03-26 | 2009-10-01 | Ada Technologies, Inc. | High performance batteries with carbon nanomaterials and ionic liquids |
| CN101981025A (zh) | 2008-03-28 | 2011-02-23 | 万有制药株式会社 | 具有黑色素浓缩激素受体拮抗作用的二芳基甲基酰胺衍生物 |
| EP2265590B8 (de) | 2008-04-15 | 2016-07-27 | Pharmacyclics LLC | Selektive histondeacetylase-hemmer |
| WO2009127686A1 (en) | 2008-04-16 | 2009-10-22 | Karo Bio Ab | Novel estrogen receptor ligands |
| DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
| WO2009131196A1 (ja) | 2008-04-24 | 2009-10-29 | 武田薬品工業株式会社 | 置換ピロリジン誘導体およびその用途 |
| EP2116539A1 (de) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon |
| WO2009137404A1 (en) | 2008-05-05 | 2009-11-12 | Amgen Inc. | Urea compounds as gamma secretase modulators |
| GB2472554B (en) | 2008-05-05 | 2012-12-05 | Ada Technologies Inc | High performance carbon nanocomposites for ultracapacitors |
| PE20091953A1 (es) | 2008-05-08 | 2010-01-09 | Du Pont | Azoles sustituidos como fungicidas |
| US8236821B2 (en) | 2008-05-19 | 2012-08-07 | Jenrin Discovery, Inc. | Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| DE102008025750A1 (de) | 2008-05-29 | 2009-12-03 | Merck Patent Gmbh | Dihydropyrazolderivate |
| BRPI0913609B8 (pt) | 2008-06-09 | 2021-05-25 | Univ Muenchen Ludwig Maximilians | composto para inibição de agregação de proteínas envolvidas em doenças ligadas à agregação de proteína e/ou doenças neurodegenerativas e em depósitos de imagem de proteína agregada, uso do mesmo, e kit |
| US20110294836A1 (en) | 2008-06-20 | 2011-12-01 | Metabolex, Inc. | Aryl gpr119 agonists and uses thereof |
| US8071595B2 (en) | 2008-06-25 | 2011-12-06 | Envivo Pharmaceuticals, Inc. | 1,2-disubstituted heterocyclic compounds |
| TWI461423B (zh) | 2008-07-02 | 2014-11-21 | Astrazeneca Ab | 用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物 |
| WO2010006006A1 (en) | 2008-07-08 | 2010-01-14 | E. I. Du Pont De Nemours And Company | Compositions comprising ionic liquids and fluoroolefins and use thereof in absorption cycle systems |
| GB0812649D0 (en) | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| GB0812648D0 (en) | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| TW201006832A (en) | 2008-07-15 | 2010-02-16 | Novartis Ag | Organic compounds |
| WO2010011657A1 (en) | 2008-07-23 | 2010-01-28 | Schering Corporation | Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| EP2318391A1 (de) | 2008-07-23 | 2011-05-11 | Schering Corporation | Tricyclische heterocyclenderivate als histamin-h3-antagonisten |
| WO2010014257A2 (en) | 2008-08-01 | 2010-02-04 | Purdue Pharma L.P. | Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof |
| JP2011530602A (ja) | 2008-08-12 | 2011-12-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｎ−ヘテロ環式ｍ１受容体ポジティブアロステリックモジュレーター |
| GB0815947D0 (en) | 2008-09-02 | 2008-10-08 | Univ Dundee | Compounds |
| US7994171B2 (en) | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8048887B2 (en) | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| EP2337778A4 (de) | 2008-09-19 | 2012-05-09 | Absolute Science Inc | Verfahren zur behandlung eines botulinumtoxin-bedingten zustandes bei einer person |
| WO2010033701A2 (en) | 2008-09-19 | 2010-03-25 | Genzyme Corporation | Inhibitors of sphingosine kinase 1 |
| EP2345328A4 (de) | 2008-09-19 | 2014-06-25 | Sumitomo Chemical Co | Zusammensetzung zur verwendung in der landwirtschaft |
| WO2010034838A2 (en) | 2008-09-29 | 2010-04-01 | Boehringer Ingelheim International Gmbh | New chemical compounds |
| EP2344450A1 (de) | 2008-09-29 | 2011-07-20 | Merck Sharp & Dohme Corp. | Substituierte arylsulfonderivate als calciumkanalblocker |
| EP2350002A1 (de) | 2008-10-02 | 2011-08-03 | Abbott Laboratories | Neue verbindungen als kalziumkanalblocker |
| EP2349308A4 (de) | 2008-10-10 | 2012-09-12 | Purdue Research Foundation | Verbindungen zur behandlung von morbus alzheimer |
| LT3135672T (lt) | 2008-10-10 | 2020-05-25 | Vm Discovery, Inc. | Kompozicijos ir būdai skirti gydyti alkoholio vartojimo sutrikimus, skausmą ir kitas ligas |
| JPWO2010044403A1 (ja) | 2008-10-15 | 2012-03-15 | キッセイ薬品工業株式会社 | ５員環ヘテロアリール誘導体及びその医薬用途 |
| CN102177138A (zh) | 2008-10-23 | 2011-09-07 | 隆萨有限公司 | 合成取代的吡唑类的方法 |
| US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
| US8722082B2 (en) | 2008-11-10 | 2014-05-13 | Tekmira Pharmaceuticals Corporation | Lipids and compositions for the delivery of therapeutics |
| CA2743553C (en) | 2008-11-19 | 2017-03-14 | Merial Limited | Dimeric 1-arylpyrazole derivatives |
| WO2010062888A2 (en) | 2008-11-26 | 2010-06-03 | E. I. Du Pont De Nemours And Company | Absorption cycle system having dual absorption circuits |
| CN101747276B (zh) | 2008-11-28 | 2011-09-07 | 中国中化股份有限公司 | 具有含氮五元杂环的醚类化合物及其应用 |
| EP2369930A4 (de) | 2008-12-02 | 2012-10-03 | Joslin Diabetes Ct | Verfahren zur senkung des blutdrucks anhand von plasma-kallikrein-hemmern |
| EP2445877B1 (de) | 2008-12-03 | 2014-07-23 | Nanotherapeutics, Inc. | Bicyclische verbindungen und verfahren zu deren herstellung und deren verwendung |
| KR101371881B1 (ko) | 2008-12-04 | 2014-03-07 | 에프. 호프만-라 로슈 아게 | 피리다진온 유도체 |
| KR101054464B1 (ko) | 2008-12-09 | 2011-08-05 | 한국화학연구원 | 3,5-디아릴-4,5-디히드로 피라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 피코르나바이러스 및 코로나바이러스에 의해 유발되는 질환의 예방 또는 치료용 조성물 |
| FR2940309A1 (fr) | 2008-12-18 | 2010-06-25 | Oreal | Colorants directs a motif pyrazoline ou tetrahydropyridazine, compositions tinctoriales les comprenant et procede de coloration |
| CA2740195A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
| MX2011006332A (es) | 2008-12-23 | 2011-06-27 | Abbott Lab | Compuestos antivirales. |
| DE102009004061A1 (de) | 2009-01-08 | 2010-07-15 | Merck Patent Gmbh | Pyridazinonderivate |
| US10053444B2 (en) | 2009-02-19 | 2018-08-21 | University Of Connecticut | Cannabinergic nitrate esters and related analogs |
| US9187455B2 (en) | 2009-02-23 | 2015-11-17 | Hoffmann-La Roche Inc. | Substituted pyridazines as PDE10A inhibitors |
| US20120035217A1 (en) | 2009-03-12 | 2012-02-09 | Biolipox Ab | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| TW201041868A (en) | 2009-03-20 | 2010-12-01 | Intervet Int Bv | Anthelmintic agents and their use |
| WO2010111059A1 (en) | 2009-03-23 | 2010-09-30 | Merck Sharp & Dohme Corp. | P2x3 receptor antagonists for treatment of pain |
| JP2012522013A (ja) | 2009-03-27 | 2012-09-20 | ザ ユーエービー リサーチ ファウンデーション | 調節ｉｒｅｓ媒介翻訳 |
| EP2414476A1 (de) | 2009-03-31 | 2012-02-08 | E. I. du Pont de Nemours and Company | Ionische verbindungen in lithiumbromid/wasser-absorptionswechselsystemen |
| JP2010248114A (ja) | 2009-04-15 | 2010-11-04 | Taisho Pharmaceutical Co Ltd | 非選択的ｐ４５０阻害剤 |
| MX2011011290A (es) | 2009-04-28 | 2012-02-13 | Boehringer Ingelheim Int | Tratamiento ex-vivo de trastornos inmunologicos con inhibidores de pkc-teta. |
| BRPI1014641A2 (pt) | 2009-04-30 | 2019-09-24 | Bayer Cropscience Ag | arilpirrolidinas pesticidas |
| US20110045101A1 (en) | 2009-05-06 | 2011-02-24 | E.I. Du Pont De Nemours And Company | Fungicidal substituted azoles |
| PT2617420E (pt) | 2009-05-07 | 2015-12-18 | Forum Pharmaceuticals Inc | Compostos heterocíclicos de fenoximetil |
| GB0908986D0 (en) | 2009-05-26 | 2009-07-01 | Univ Belfast | Process for removing organic acids from crude oil and crude oil distillates |
| US8680150B2 (en) | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
| GB2470590B (en) | 2009-05-29 | 2014-07-23 | Astron Advanced Materials Ltd | Electrodeposition of elemental zirconium |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| RU2417082C2 (ru) | 2009-07-14 | 2011-04-27 | Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) | Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения |
| GB0912946D0 (en) | 2009-07-24 | 2009-09-02 | Addex Pharmaceuticals Sa | New compounds 5 |
| UA108619C2 (xx) | 2009-08-07 | 2015-05-25 | Пестицидні композиції | |
| EP2292236A1 (de) | 2009-08-14 | 2011-03-09 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Vorbeugung oder Behandlung von Schmerzen infolge von Chemotherapie |
| EP2473501B1 (de) | 2009-09-03 | 2019-02-20 | Allergan, Inc. | Verbindungen als tyrosinkinasemodulatoren |
| US8906944B2 (en) | 2009-09-03 | 2014-12-09 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| GB2473285A (en) | 2009-09-08 | 2011-03-09 | Astron Advanced Materials Ltd | Low temperature joining process |
| JP2011057609A (ja) | 2009-09-09 | 2011-03-24 | Daicel Chemical Industries Ltd | カップリング化合物の製造方法およびカップリング触媒 |
| EP2480531B1 (de) | 2009-09-21 | 2014-11-05 | ChemoCentryx, Inc. | Pyrolidoncarboxamide-derivate als chemerin-r (chemr23) modulatoren |
| WO2011038261A1 (en) | 2009-09-24 | 2011-03-31 | Selexagen Therapeutics, Inc. | Heterocyclic kinase inhibitors |
| EP2308850A1 (de) | 2009-10-06 | 2011-04-13 | Laboratorios Del. Dr. Esteve, S.A. | Heterocyclylsubstituierte Alkylaminophenyl-Derivate, ihre Herstellung und Verwendung als Arzneimittel |
| EP2308849A1 (de) | 2009-10-06 | 2011-04-13 | Laboratorios Del. Dr. Esteve, S.A. | Indanamin-Derivate, ihre Herstellung und Verwendung als Arzneimittel |
| KR20120083905A (ko) | 2009-10-09 | 2012-07-26 | 자프겐 코포레이션 | 비만의 치료에 사용하기 위한 설폰 화합물 |
| KR20120129869A (ko) | 2009-10-22 | 2012-11-28 | 벤더르빌트 유니버시티 | Ｍｇｌｕｒ4 알로스테릭 강화제, 조성물 및 신경 기능이상을 치료하는 방법 |
| JP2011093855A (ja) | 2009-10-30 | 2011-05-12 | Bayer Cropscience Ag | 殺虫性オキサゾリジノン誘導体 |
| WO2011051198A2 (de) | 2009-10-30 | 2011-05-05 | Bayer Cropscience Ag | Pyridin-derivate als pflanzenschutzmittel |
| EP2335688A1 (de) | 2009-11-25 | 2011-06-22 | Laboratorios Del. Dr. Esteve, S.A. | Pharmazeutische Zusammensetzungen, die Sigmarezeptorliganden umfassen |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| PH12012501536A1 (en) | 2010-01-27 | 2012-10-22 | Gb007 Inc | Pyrazole compounds as crth2 antagonists |
| JP5620115B2 (ja) | 2010-02-02 | 2014-11-05 | 富士フイルム株式会社 | 顔料微粒子分散体、これを用いた光硬化性組成物及びカラーフィルタ、これに用いられる新規化合物 |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| TW201130488A (en) | 2010-02-03 | 2011-09-16 | Daiichi Sankyo Co Ltd | Pyrrole compound |
| EP2353598A1 (de) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz |
| EP2353591A1 (de) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon |
| RS57309B1 (sr) | 2010-02-16 | 2018-08-31 | Aragon Pharmaceuticals Inc | Modulatori androgenih receptora i njihove upotrebe |
| WO2011106650A2 (en) | 2010-02-27 | 2011-09-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| JP2013522192A (ja) | 2010-03-11 | 2013-06-13 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎の処置のための化合物 |
| JP5938352B2 (ja) | 2010-03-11 | 2016-06-22 | ギリアード コネチカット， インコーポレイテッド | イミダゾピリジンｓｙｋ阻害剤 |
| US20110223093A1 (en) | 2010-03-12 | 2011-09-15 | E.I. Du Pont De Nemours And Comapny | Ionic liquid systems for carbon dioxide and sulfur dioxide removal |
| US20110220506A1 (en) | 2010-03-12 | 2011-09-15 | E. I. Du Pont De Nemours And Company | Recovery of materials from mixtures with ionic liquids |
| US9072999B2 (en) | 2010-03-12 | 2015-07-07 | E I Du Pont De Nemours And Company | Aromatic amino compounds for carbon dioxide and sulfur dioxide removal |
| US20110223084A1 (en) | 2010-03-12 | 2011-09-15 | E. I. Du Pont De Nemours And Company | Sulfur functionalized ionic liquid compounds for carbon dioxide and sulfur dioxide removal |
| US20110223085A1 (en) | 2010-03-12 | 2011-09-15 | E. I. Du Pont De Nemours And Company | Carbon dioxide capture with ionic liquid electrospray |
| US9067953B2 (en) | 2010-03-12 | 2015-06-30 | E I Du Pont De Nemours And Company | Systems for carbon dioxide and sulfur dioxide removal |
| NZ700332A (en) | 2010-03-30 | 2017-06-30 | Verseon Corp | Multisubstituted aromatic compounds as inhibitors of thrombin |
| GB201005589D0 (en) | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
| US9024041B2 (en) | 2010-04-08 | 2015-05-05 | Respivert Ltd. | P38 MAP kinase inhibitors |
| US9260410B2 (en) | 2010-04-08 | 2016-02-16 | Respivert Ltd. | P38 MAP kinase inhibitors |
| GB201006167D0 (en) | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| WO2011132017A1 (en) | 2010-04-19 | 2011-10-27 | Glenmark Pharmaceuticals S.A. | Pyrido[3,4-d]pyrimidinyl acetamide derivatives as trpa1 modulators |
| GB201007187D0 (en) | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination modulators |
| CN103118682A (zh) | 2010-04-30 | 2013-05-22 | 加利福尼亚大学校务委员会 | 合成tlr7激动剂的磷脂缀合物的用途 |
| MX338700B (es) | 2010-05-06 | 2016-04-28 | Graham Packaging Co | Aditivos para depuracion de oxigeno para recipientes de plastico. |
| US9062008B2 (en) | 2010-05-12 | 2015-06-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| CA2798325A1 (en) | 2010-05-13 | 2011-11-17 | Amgen Inc. | Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| CN103221404B (zh) | 2010-05-13 | 2015-12-16 | 安姆根有限公司 | 可用作pde10抑制剂的不饱和氮杂环化合物 |
| WO2011145669A1 (ja) | 2010-05-19 | 2011-11-24 | 大日本住友製薬株式会社 | アミド誘導体 |
| EP2388005A1 (de) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie |
| TW201209054A (en) | 2010-05-28 | 2012-03-01 | Prosidion Ltd | Novel compounds |
| US9017455B2 (en) | 2010-06-03 | 2015-04-28 | E I Du Pont De Nemours And Company | Sulfur compounds for carbon dioxide and sulfur dioxide removal |
| BR112012032247A2 (pt) | 2010-06-15 | 2015-09-15 | Bayer Ip Gmbh | derivados de ácido antranílico |
| JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用 |
| DK178277B1 (da) | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
| US8492424B2 (en) | 2010-07-01 | 2013-07-23 | Allergan, Inc. | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| US8859606B2 (en) | 2010-07-01 | 2014-10-14 | Allergan, Inc. | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| WO2012002913A1 (en) | 2010-07-02 | 2012-01-05 | Nanyang Technological University | Process of forming a cyclic imide |
| JP5889895B2 (ja) | 2010-07-29 | 2016-03-22 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Ａｍｐｋ活性化複素環化合物およびその使用方法 |
| EP2415471A1 (de) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie |
| WO2012024179A1 (en) | 2010-08-18 | 2012-02-23 | Merck Sharp & Dohme Corp. | Substituted amide derivatives as dgat-1 inhibitors |
| JP2012082186A (ja) | 2010-09-15 | 2012-04-26 | Bayer Cropscience Ag | 殺虫性アリールピロリジン類 |
| WO2012041524A1 (en) | 2010-10-01 | 2012-04-05 | Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) | Hydrazonopyrazolones as protein tyrosine phosphatase inhibitors |
| JP2014005206A (ja) | 2010-10-22 | 2014-01-16 | Astellas Pharma Inc | アリールアミノヘテロ環カルボキサミド化合物 |
| BR112013009823A2 (pt) | 2010-10-22 | 2016-07-05 | Bayer Ip Gmbh | novos compostos heterocíclicos como pesticidas |
| JP5909239B2 (ja) | 2010-10-26 | 2016-04-26 | マーズ インコーポレイテッド | アルギナーゼ阻害剤としてのボロネート |
| WO2012058176A1 (en) | 2010-10-29 | 2012-05-03 | Schering Corporation | Novel heteroaryl-carboxamide derivatives as pdk1 inhibitors |
| JP2014015397A (ja) | 2010-11-04 | 2014-01-30 | Nippon Soda Co Ltd | 動物用外部寄生虫防除剤 |
| WO2012062783A1 (en) | 2010-11-10 | 2012-05-18 | F. Hoffmann-La Roche Ag | Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
| EP2457900A1 (de) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten |
| GB2485824B (en) | 2010-11-25 | 2017-12-20 | The Queen's Univ Of Belfast | Process for removing organic acids from crude oil and crude oil distillates |
| EP2460519A1 (de) | 2010-12-03 | 2012-06-06 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei Knochenkrebsschmerz |
| CN102485743A (zh) | 2010-12-06 | 2012-06-06 | 北京韩美药品有限公司 | 抗肿瘤化合物 |
| BR112013014019A2 (pt) | 2010-12-07 | 2016-09-13 | Amira Pharmaceuticals Inc | antagonistas do receptor do ácido lisofosfatídico e seus usos |
| JP5728921B2 (ja) | 2010-12-10 | 2015-06-03 | コニカミノルタ株式会社 | 光学フィルム、及びそれを用いた偏光板、液晶表示装置 |
| PL2655345T3 (pl) | 2010-12-20 | 2015-07-31 | Sigma Tau Res Switzerland Sa | Związki arylo-triazolowe o aktywności przeciwnowotworowej |
| KR20120077469A (ko) | 2010-12-30 | 2012-07-10 | 제일모직주식회사 | 액정 배향제, 이를 이용하여 제조한 액정 배향막 및 상기 액정 배향막을 포함하는 액정표시소자 |
| US20120184572A1 (en) | 2011-01-13 | 2012-07-19 | Metabolex, Inc. | Aryl gpr119 agonists and uses thereof |
| MX351305B (es) | 2011-01-20 | 2017-10-09 | Merck Sharp & Dohme | Antagonistas del receptor de mineralocorticoides. |
| AP3447A (en) | 2011-02-07 | 2015-10-31 | Dow Agrisciences Llc | Pesticidal compositions and processes related thereto |
| US20120214842A1 (en) | 2011-02-18 | 2012-08-23 | Exonhit Therapeutics Sa | Methods for treating diseases of the retina |
| BR102012004142A2 (pt) | 2011-02-25 | 2015-04-07 | Dow Agrosciences Llc | Composições pesticidas e processos relacionados às mesmas |
| KR101821226B1 (ko) | 2011-03-01 | 2018-01-23 | 엔파마콘, 엘엘씨 | Ｎ-(４-메톡시페닐)-１-페닐-1ｈ-피라졸-３-아민 및 관련 화합물의 사용 |
| US9169260B2 (en) | 2011-03-22 | 2015-10-27 | Merck Sharp & Dohme Corp. | Amidopyrazole inhibitors of interleukin receptor-associated kinases |
| EP2694521B1 (de) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidin-kondensierte thiadiazindioxidverbindungen als bace-hemmer, zusammensetzungen daraus und ihre verwendung |
| AU2012250788B2 (en) | 2011-05-03 | 2017-03-02 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| US20120283366A1 (en) | 2011-05-06 | 2012-11-08 | Graham Packaging Company, L.P. | Activated oxygen scavenging compositions for plastic containers |
| EP2524694A1 (de) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes |
| EP2714041B1 (de) | 2011-05-24 | 2016-10-19 | Merck Sharp & Dohme Corp. | Aryloxymethyl-cyclopropanderivate als pde10-hemmer |
| PT2713722T (pt) | 2011-05-31 | 2017-06-27 | Receptos Llc | Novos estabilizadores e moduladores do receptor glp-1 |
| US20120304682A1 (en) | 2011-06-02 | 2012-12-06 | E.I. Du Pont De Nemours And Company | Absorption Cycle System Having Dual Absorption Circuits |
| CA2877474A1 (en) | 2011-06-20 | 2012-12-27 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
| CN103826452B (zh) | 2011-07-12 | 2017-02-01 | 陶氏益农公司 | 杀虫组合物及其相关方法 |
| EP2550863A1 (de) | 2011-07-27 | 2013-01-30 | Bayer Intellectual Property GmbH | Aktivstoffhaltige Partikel auf Polyacrylat-Basis |
| SI2739153T1 (sl) | 2011-07-29 | 2018-12-31 | Medivation Prostate Therapeutics Llc | Zdravljenje raka dojke |
| JP5955961B2 (ja) | 2011-08-12 | 2016-07-20 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | Ｎ−置換１ｈ−ピラゾール５−カルボニルクロリド化合物を製造するための方法 |
| BR112014003220A2 (pt) | 2011-08-12 | 2017-03-01 | Basf Se | composto de fórmula (i), processo para preparar um composto de fórmula i e v, uso do composto de fórmula i, método para controlar uma praga invertebrada, forma cristalina, uso das formas cristalinas e método para controlar uma praga invertebrada |
| JP2014524459A (ja) | 2011-08-25 | 2014-09-22 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | シロアリおよびアリの防除方法 |
| US9168507B2 (en) | 2011-09-23 | 2015-10-27 | Sigma-Aldrich Co., Llc | Methods for quantitating water using ionic liquid salts |
| EP2766355B1 (de) | 2011-10-11 | 2020-12-23 | Dana-Farber Cancer Institute, Inc. | Pyrazol-3-one zur aktivierung von pro-apoptotischem bax |
| US9289365B2 (en) | 2011-10-24 | 2016-03-22 | Avon Products, Inc. | Compositions and methods for stimulating collagen synthesis in the skin |
| WO2013062027A1 (ja) | 2011-10-27 | 2013-05-02 | 大正製薬株式会社 | アゾール誘導体 |
| CN103087050A (zh) | 2011-10-28 | 2013-05-08 | 山东轩竹医药科技有限公司 | 芳基激酶抑制剂 |
| US9044408B2 (en) | 2011-10-31 | 2015-06-02 | Avon Products, Inc. | Cosmetic use of N-heteroarylbisamide analogs and related compounds |
| WO2013067142A1 (en) | 2011-11-02 | 2013-05-10 | Medivation Technologies, Inc. | Compounds and treatment methods |
| MX352738B (es) | 2011-11-17 | 2017-12-06 | Pfizer | Peptidos citotoxicos y conjugados de anticuerpo-farmaco de los mismos. |
| BR112014012942A2 (pt) | 2011-11-29 | 2017-06-13 | Novartis Ag | uso de derivados de aril para controle de ectoparasitas |
| WO2013085890A1 (en) | 2011-12-06 | 2013-06-13 | Glaxo Group Limited | Therapeutic methods |
| CN103159736B (zh) | 2011-12-10 | 2015-05-13 | 通化济达医药有限公司 | 取代的吡唑激酶抑制剂 |
| RU2634896C2 (ru) | 2011-12-12 | 2017-11-08 | Селджин Интернэшнл Ii Сарл | Новые модуляторы рецептора glp-1 |
| JP2015500317A (ja) | 2011-12-14 | 2015-01-05 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 有害生物防除混合物 |
| TW201332988A (zh) | 2011-12-23 | 2013-08-16 | Millennium Pharm Inc | 雜芳基化合物及其用途 |
| CA2862263C (en) | 2011-12-27 | 2016-09-06 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| CN104136978A (zh) | 2011-12-28 | 2014-11-05 | 日产化学工业株式会社 | 液晶取向剂、液晶显示元件、液晶显示元件的制造方法及聚合性化合物 |
| KR20130077390A (ko) | 2011-12-29 | 2013-07-09 | 제이더블유중외제약 주식회사 | 단백질 키나아제 저해활성을 가지는 6-아미노-3-카복스아미도인다졸 유도체 |
| EP3327017B1 (de) | 2012-01-10 | 2019-04-24 | Merck Patent GmbH | Benzamidderivate als modulatoren des follikelstimulierenden hormons |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| AR092790A1 (es) | 2012-02-01 | 2015-05-06 | Euro Celtique Sa | Derivados bencimidazolicos del acido hidroxamico |
| WO2013116491A1 (en) | 2012-02-01 | 2013-08-08 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds and methods for using them |
| GB2498976A (en) | 2012-02-01 | 2013-08-07 | Prosidion Ltd | GPR119 agonists useful in the treatment of type II diabetes |
| WO2013116052A1 (en) | 2012-02-02 | 2013-08-08 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US8916183B2 (en) | 2012-02-02 | 2014-12-23 | Dow Agrosciences, Llc. | Pesticidal compositions and processes related thereto |
| WO2013123071A1 (en) | 2012-02-13 | 2013-08-22 | Cleave Biosciences, Inc. | Methods and compositions for jamm protease inhibition |
| WO2013131018A1 (en) | 2012-03-02 | 2013-09-06 | Zalicus Pharmaceuticals Ltd. | Biaryl inhibitors of the sodium channel |
| SG11201404649UA (en) | 2012-03-07 | 2014-09-26 | Cadila Healthcare Ltd | Novel compounds for the treatment of dyslipidemia and related diseases |
| CN103304552B (zh) | 2012-03-09 | 2016-12-28 | 广东东阳光药业有限公司 | 取代的吡啶化合物及其使用方法和用途 |
| WO2013138210A1 (en) | 2012-03-14 | 2013-09-19 | Ning Xi | Substituted cyclic compounds and methods of use |
| WO2013142396A1 (en) | 2012-03-23 | 2013-09-26 | Merck Sharp & Dohme Corp. | N3-substituted iminopyrimidinones as renin inhibitors, compositions, and their use |
| CN104302644A (zh) | 2012-03-23 | 2015-01-21 | 日本农药株式会社 | 噻唑甲酰胺衍生物及其使用方法 |
| JP5826206B2 (ja) | 2012-03-29 | 2015-12-02 | 富士フイルム株式会社 | 非線形光学材料及びそれを用いた非線形光学素子 |
| EP2847174B1 (de) | 2012-04-03 | 2017-05-17 | Bristol-Myers Squibb Company | Pyrimidinon carboxamide als inhibitoren der endothellipase |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| SG10201509063SA (en) | 2012-04-12 | 2015-12-30 | Univ Leland Stanford Junior | Substituted benzamides and their uses |
| WO2013157021A1 (en) | 2012-04-20 | 2013-10-24 | Advinus Therapeutics Limited | Bicyclic compounds, compositions and medicinal applications thereof |
| WO2013163404A1 (en) | 2012-04-27 | 2013-10-31 | The Uab Research Foundation | TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM |
| IN2014MN02127A (de) | 2012-05-02 | 2015-09-11 | Lupin Ltd | |
| US20150166591A1 (en) | 2012-05-05 | 2015-06-18 | Ariad Pharmaceuticals, Inc. | Methods and compositions for raf kinase mediated diseases |
| WO2013168565A1 (ja) | 2012-05-07 | 2013-11-14 | 山本化成株式会社 | 樹脂組成物および成形体 |
| WO2013172943A1 (en) | 2012-05-16 | 2013-11-21 | Graham Packaging Company, L.P. | Low phosphorous oxygen scavenging compositions requiring no induction period |
| CN103420991B (zh) | 2012-05-17 | 2017-07-07 | 乳源东阳光药业有限公司 | 作为丙型肝炎抑制剂的吡咯烷衍生物及其在药物中的应用 |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| ITMI20120980A1 (it) | 2012-06-06 | 2013-12-07 | Fond Roma | Pirrolil-idrossammati per uso nella prevenzione e/o nel trattamento di infezioni batteriche. |
| EP2676954A1 (de) | 2012-06-19 | 2013-12-25 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituierte Phenylderivate als Vasodilatoren |
| WO2014002106A1 (en) | 2012-06-25 | 2014-01-03 | Cadila Healthcare Limited | Novel compounds for the treatment of dyslipidemia and related diseases |
| US9682970B2 (en) | 2012-06-29 | 2017-06-20 | Biotium, Inc. | Fluorescent compounds and uses thereof |
| US8815772B2 (en) | 2012-06-29 | 2014-08-26 | E I Du Pont De Nemours And Company | Fungicidal heterocyclic carboxamides |
| TWI654180B (zh) | 2012-06-29 | 2019-03-21 | 美商艾佛艾姆希公司 | 殺真菌之雜環羧醯胺 |
| JP2015525758A (ja) | 2012-07-09 | 2015-09-07 | ダウ アグロサイエンシィズ エルエルシー | 農薬組成物およびそれらに関する方法 |
| CN103565653B (zh) | 2012-07-16 | 2017-01-25 | 广东东阳光药业有限公司 | 取代的吡唑酮化合物及其使用方法和用途 |
| EP2875014B1 (de) | 2012-07-17 | 2017-11-29 | Washington University | Schleimlösungsarzneien und verwendungen dafür |
| WO2014022116A2 (en) | 2012-07-28 | 2014-02-06 | Calitor Sciences, Llc | Substituted pyrazolone compounds and methods of use |
| US8975282B2 (en) | 2012-07-28 | 2015-03-10 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrazolone compounds and methods of use |
| BR112015001908A2 (pt) | 2012-07-31 | 2017-07-04 | Syngenta Participations Ag | métodos de controle de pragas em soja |
| AP2015008203A0 (en) | 2012-08-10 | 2015-01-31 | Boehringer Ingelheim Int | Heteroaromatic compounds as bruton's tyrosine kinase (BTK) inhibitors |
| WO2014029708A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of controlling insects |
| CN104582483A (zh) | 2012-08-24 | 2015-04-29 | 先正达参股股份有限公司 | 土壤有害生物控制的方法 |
| AU2013305633B2 (en) | 2012-08-24 | 2018-03-08 | Board Of Regents, The University Of Texas System | Heterocyclic modulators of HIF activity for treatment of disease |
| US20150189884A1 (en) | 2012-08-24 | 2015-07-09 | Syngenta Participations Ag | Methods of controlling insects |
| WO2014031933A2 (en) | 2012-08-24 | 2014-02-27 | Philip Jones | Heterocyclic modulators of hif activity for treatment of disease |
| CN104602526A (zh) | 2012-08-24 | 2015-05-06 | 先正达参股股份有限公司 | 控制昆虫的方法 |
| GB201215357D0 (en) | 2012-08-29 | 2012-10-10 | Respivert Ltd | Compounds |
| MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| DE102012018115A1 (de) | 2012-09-13 | 2014-03-13 | Matthias Lehr | Aryl-N-(arylalkyl)carbamate als Hemmstoffe der Fatty Acid Amide Hydrolase |
| WO2014046283A1 (ja) | 2012-09-21 | 2014-03-27 | 富士フイルム株式会社 | 非水二次電池用電解液および非水二次電池 |
| EP2900237A1 (de) | 2012-09-25 | 2015-08-05 | Novartis AG | Verbindungen zur verwendung bei magenkomplikationen |
| BR112015006243A2 (pt) | 2012-09-26 | 2017-07-04 | Zoetis Llc | agentes antibacterianos de fenicol |
| WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP2909194A1 (de) | 2012-10-18 | 2015-08-26 | Dana-Farber Cancer Institute, Inc. | Hemmer der cyclinabhängigen kinase 7 (cdk7) |
| US9567301B2 (en) | 2012-11-02 | 2017-02-14 | Dana-Farber Cancer Institute, Inc. | Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors |
| CN103804358B (zh) | 2012-11-14 | 2016-06-29 | 上海医药集团股份有限公司 | 一类二芳基乙内酰脲衍生物、其制备方法、药物组合物和应用 |
| CN103804108B (zh) | 2012-11-15 | 2016-08-03 | 沈阳药科大学 | 一种制备伯胺的方法 |
| JP2016504282A (ja) | 2012-11-16 | 2016-02-12 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ジヒドロピラゾールｇｐｒ４０モジュレーター |
| EA201590951A1 (ru) | 2012-11-16 | 2015-08-31 | Бристол-Майерс Сквибб Компани | Дигидропиразольные модуляторы gpr40 |
| CA2891569A1 (en) | 2012-11-16 | 2014-05-22 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators |
| CN103833753B (zh) | 2012-11-22 | 2017-02-01 | 广东东阳光药业有限公司 | 炔基化合物及其使用方法和用途 |
| US20140148484A1 (en) | 2012-11-23 | 2014-05-29 | Boehringer Ingelheim International Gmbh | Pyrazole compounds for treating hairloss |
| US20140148430A1 (en) | 2012-11-26 | 2014-05-29 | Gilead Connecticut, Inc. | Imidazopyridines syk inhibitors |
| CN103848810A (zh) | 2012-11-30 | 2014-06-11 | 北京赛林泰医药技术有限公司 | 鲁顿酪氨酸激酶抑制剂 |
| WO2014089280A1 (en) | 2012-12-07 | 2014-06-12 | Calitor Sciences, Llc | Alkynyl compounds and methods of use |
| US9475817B2 (en) | 2012-12-21 | 2016-10-25 | Bristol-Myers Squibb Company | Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors |
| GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
| JP6288412B2 (ja) | 2013-01-17 | 2018-03-07 | Jsr株式会社 | 液晶配向剤 |
| WO2014114250A1 (en) | 2013-01-23 | 2014-07-31 | Syngenta Participations Ag | Pyrazoline derivatives as insecticidal compounds |
| CN103965170A (zh) | 2013-01-24 | 2014-08-06 | 通化济达医药有限公司 | 苯磺酰胺吡唑激酶抑制剂 |
| KR102065586B1 (ko) | 2013-01-30 | 2020-01-14 | 삼성디스플레이 주식회사 | 유기금속 착체 및 이를 포함한 유기 발광 소자 |
| EP2952510B1 (de) | 2013-02-02 | 2018-12-26 | Chia Tai Tianqing Pharmaceutical Group Co.,Ltd | Substituierte 2-aminopyridinproteinkinasehemmer |
| US9695189B2 (en) | 2013-03-01 | 2017-07-04 | Mark Quang Nguyen | Chemical crosslinkers and compositions thereof |
| WO2014159214A1 (en) | 2013-03-14 | 2014-10-02 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
| US20180044332A1 (en) | 2013-03-14 | 2018-02-15 | Dow Agrosciences Llc | Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto |
| CN105120867A (zh) | 2013-03-14 | 2015-12-02 | 广州源生医药科技有限公司 | 用于治疗纤维化疾病的化合物 |
| KR102194088B1 (ko) | 2013-03-14 | 2020-12-22 | 다우 아그로사이언시즈 엘엘씨 | 특정 살충 유용성을 갖는 분자, 및 그와 관련된 중간체, 조성물 및 방법 |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| DK2967049T3 (da) | 2013-03-15 | 2020-12-07 | Univ Southern California | Metoder, forbindelser og sammensætninger til behandlingen af angiotensin relaterede sygdomme |
| MX2015012867A (es) | 2013-03-15 | 2016-06-10 | Verseon Corp | Compuestos aromaticos multisustituidos como inhibidores de serina proteasa. |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| AU2014232383B2 (en) | 2013-03-15 | 2019-01-17 | Epigen Biosciences, Inc. | Heterocyclic compounds useful in the treatment of disease |
| US20160024098A1 (en) | 2013-03-15 | 2016-01-28 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| KR101506869B1 (ko) | 2013-03-26 | 2015-04-08 | 한국교통대학교산학협력단 | 피라졸 유도체 및 이를 채용한 유기전계발광소자 |
| US9295731B2 (en) | 2013-04-01 | 2016-03-29 | Mark Quang Nguyen | Cleavable drug conjugates, compositions thereof and methods of use |
| US20150284313A1 (en) | 2013-04-11 | 2015-10-08 | California Institute Of Technology | Reactions in the presence of ruthenium complexes |
| US9249170B2 (en) | 2013-04-11 | 2016-02-02 | California Institute Of Technology | Cyclic alkyl amino carbene (CAAC) ruthenium complexes as improved catalysts for ethenolysis reactions |
| BR112015025647A2 (pt) | 2013-04-15 | 2017-07-18 | Du Pont | composto, composição fungicida e método para o controle das doenças dos vegetais |
| EP2792352A1 (de) | 2013-04-16 | 2014-10-22 | Laboratorios Del. Dr. Esteve, S.A. | Alpha-2-Adrenorezeptor und Sigmarezeptor-Ligande enthaltenden Kombinationen |
| JP6387669B2 (ja) | 2013-04-26 | 2018-09-12 | 大正製薬株式会社 | アゾール誘導体を含有する医薬 |
| WO2014183164A1 (en) | 2013-05-17 | 2014-11-20 | Naresh Kumar | Dihydropyrrolones and their use as antimicrobial agents |
| CN104177338B (zh) | 2013-05-22 | 2018-04-03 | 南京勇山生物科技有限公司 | 一类布鲁顿激酶抑制剂 |
| EP2999697B1 (de) | 2013-05-23 | 2017-04-19 | Kalvista Pharmaceuticals Limited | Heterocyclische derivate |
| CN104230946B (zh) | 2013-06-06 | 2017-03-08 | 爱博新药研发(上海)有限公司 | 抑制丙肝病毒的化合物、药物组合物及其应用 |
| WO2014195402A1 (en) | 2013-06-06 | 2014-12-11 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| JP6184830B2 (ja) | 2013-06-14 | 2017-08-23 | 花王株式会社 | 漂白洗浄剤組成物 |
| BR112015031291A2 (pt) | 2013-06-20 | 2017-07-25 | Bayer Cropscience Ag | derivados de sulfureto de arila e derivados de arilalquil sulfóxido como acaricidas e inseticidas |
| US9981928B2 (en) | 2013-06-20 | 2018-05-29 | Bayer Cropscience Aktiengesellschaft | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides |
| WO2014205414A1 (en) | 2013-06-21 | 2014-12-24 | The Regents Of The University Of California | Expanded therapeutic potential in nitroheteroaryl antimicrobials |
| EP3010888A1 (de) | 2013-06-21 | 2016-04-27 | Basf Se | Strobilurin-verbindungen zur bekämpfung phytopathogener pilze |
| EP2818166A1 (de) | 2013-06-26 | 2014-12-31 | Laboratorios del Dr. Esteve S.A. | Verwendung von sigma-Rezeptorliganden zur Vorbeugung und Behandlung von Schmerzen im Zusammenhang mit interstitieller Zystitis/Blasenschmerzsyndrom (IC/BPS) |
| WO2015002926A1 (en) | 2013-07-02 | 2015-01-08 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| JP2016525562A (ja) | 2013-08-02 | 2016-08-25 | インスティチュート パスツール コリア | 抗感染症化合物 |
| IN2013MU02611A (de) | 2013-08-07 | 2015-06-12 | Cadila Healthcare Ltd | |
| EP3033089A2 (de) | 2013-08-16 | 2016-06-22 | The Regents of The University of California | Verwendung von phospholipid-konjugaten aus synthetischen tlr7-agonisten |
| WO2015035051A1 (en) | 2013-09-04 | 2015-03-12 | Board Of Regents Of The University Of Texas System | Methods and compositions for selective and targeted cancer therapy |
| AR100021A1 (es) | 2013-09-12 | 2016-09-07 | Esteve Labor Dr | Combinaciones de ligando de receptores sigma y aine |
| US20150082981A1 (en) | 2013-09-20 | 2015-03-26 | E I Du Pont De Nemours And Company | Capture of trifluoromethane using ionic liquids |
| WO2015048547A2 (en) | 2013-09-26 | 2015-04-02 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| MX2016004030A (es) | 2013-09-30 | 2016-10-26 | Beijing Synercare Pharma Tech Co Ltd | Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune. |
| WO2015054283A1 (en) | 2013-10-08 | 2015-04-16 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| ITTO20130816A1 (it) | 2013-10-09 | 2015-04-10 | Fond Istituto Italiano Di Tecnologia | Antagonisti di rev-erb diarilalchilaminici e loro uso come farmaci |
| CN105849099B (zh) | 2013-10-18 | 2020-01-17 | 达纳-法伯癌症研究所股份有限公司 | 周期蛋白依赖性激酶7(cdk7)的多环抑制剂 |
| LT3066080T (lt) | 2013-11-05 | 2018-09-10 | Bayer Cropscience Aktiengesellschaft | Nauji junginiai kovai su artropodais |
| WO2015069287A1 (en) | 2013-11-08 | 2015-05-14 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| WO2015070367A1 (en) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| CA3213014A1 (en) | 2013-12-03 | 2015-06-11 | Fmc Corporation | Pyrrolidinones as herbicides |
| CN104692985B (zh) | 2013-12-06 | 2019-05-17 | 中国科学院上海有机化学研究所 | 钯催化合成α-芳基、杂芳基或烯基-α,α-二氟烯丙基结构的方法 |
| CN104710436B (zh) | 2013-12-13 | 2017-07-28 | 沈阳中化农药化工研发有限公司 | 一种吡唑基嘧啶胺类化合物及用途 |
| MA39147B1 (fr) | 2013-12-17 | 2019-12-31 | Esteve Labor Dr | Combinaisons d'inhibiteurs de la recapture de sérotonine-norépinéphrine (snri) et de ligands des récepteurs sigma |
| JP2017503765A (ja) | 2013-12-17 | 2017-02-02 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | ガバペンチノイドおよびシグマ受容体の組み合わせ |
| EP3092229B1 (de) | 2014-01-06 | 2018-03-28 | Bristol-Myers Squibb Company | Pyrrolidinylsulfonderivate und ihre verwendung als ror gamma modulatoren |
| CN112920180A (zh) | 2014-01-06 | 2021-06-08 | 理森制药股份公司 | 谷氨酰胺酶抑制剂 |
| WO2015123437A1 (en) | 2014-02-13 | 2015-08-20 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
| PT3105226T (pt) | 2014-02-13 | 2019-11-06 | Incyte Corp | Ciclopropilaminas como inibidores de lsd1 |
| LT3105218T (lt) | 2014-02-13 | 2019-12-10 | Incyte Corp | Ciklopropilaminai kaip lsd1 inhibitoriai |
| WO2015130790A2 (en) | 2014-02-25 | 2015-09-03 | Board Of Regents, University Of Texas System | Salts of heterocyclic modulators of hif activity for treatment of disease |
| CN103864753B (zh) | 2014-02-27 | 2016-01-20 | 华东师范大学 | 含有五元芳杂环结构的抗丙肝化合物及制备方法和用途 |
| MA53399B1 (fr) | 2014-03-07 | 2022-10-31 | Biocryst Pharm Inc | Pyrazoles substitués en tant qu`inhibiteurs de la kallicréine plasmatique humaine |
| AU2015240535A1 (en) | 2014-04-04 | 2016-10-20 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| EP3129371B1 (de) | 2014-04-05 | 2020-07-29 | Syros Pharmaceuticals, Inc. | Inhibitoren der cyclin-abhängigen kinase 7 (cdk7) |
| TWI690521B (zh) | 2014-04-07 | 2020-04-11 | 美商同步製藥公司 | 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類 |
| WO2015161014A1 (en) | 2014-04-17 | 2015-10-22 | Merck Sharp & Dohme Corp. | Heterocyclic cgrp receptor antagonists |
| WO2015162133A1 (en) | 2014-04-22 | 2015-10-29 | Basf Se | C3-c4-cycloalkenyl-comprising pyrazoles for controlling invertebrate pests |
| US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
| TW201623239A (zh) | 2014-04-24 | 2016-07-01 | 田邊三菱製藥股份有限公司 | 新穎２－胺基－吡啶及２－胺基－嘧啶衍生物及其醫藥用途 |
| WO2015169734A1 (en) | 2014-05-05 | 2015-11-12 | Basf Se | Pyrazoles for controlling invertebrate pests |
| US9873679B2 (en) | 2014-05-07 | 2018-01-23 | Bristol-Myers Squibb Company | Pyrrolidine GPR40 modulators |
| US10301260B2 (en) | 2014-05-07 | 2019-05-28 | Bristol-Myers Squibb Company | Pyrrolidine GPR40 modulators |
| TWI699364B (zh) | 2014-05-23 | 2020-07-21 | 瑞士商赫孚孟拉羅股份公司 | ５-氯-２-二氟甲氧基苯基吡唑并嘧啶化合物、組合物及其使用方法 |
| EP3159342B1 (de) | 2014-06-17 | 2020-08-05 | Cisen Pharmaceutical Co., Ltd. | Als mtor/pi3k-inhibitor verwendete pyridino[1,2-a]pyrimidon-analoga |
| WO2016004280A2 (en) | 2014-07-02 | 2016-01-07 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| LT3164394T (lt) | 2014-07-03 | 2020-05-25 | Board Of Regents, The University Of Texas System | Gls1 inhibitoriai, skirti ligų gydymui |
| US20160002204A1 (en) | 2014-07-03 | 2016-01-07 | Board Of Regents, The University Of Texas System | Gls1 inhibitors for treating disease |
| CN106470683A (zh) | 2014-07-11 | 2017-03-01 | 英特维特国际股份有限公司 | 针对犬心丝虫的抗蠕虫剂的用途 |
| CN104130189B (zh) | 2014-07-11 | 2017-01-18 | 四川理工学院 | 吡唑啉衍生物及作为金属酸洗缓蚀剂的应用 |
| AU2015227454B2 (en) | 2014-07-16 | 2016-02-25 | Novogen ltd | Functionalised and substituted indoles as anti-cancer agents |
| US9963463B2 (en) | 2014-08-29 | 2018-05-08 | Torrent Pharmaceuticals Limited | Urea-substituted indanes as P38 map kinase inhibitors |
| TWI663218B (zh) | 2014-09-04 | 2019-06-21 | 日商富士軟片股份有限公司 | 組成物、組成物的製造方法、硬化性組成物、硬化膜、近紅外線截止濾波器、固體攝像元件、紅外線感測器、照相機模組及化合物 |
| ES2760266T3 (es) | 2014-09-09 | 2020-05-13 | Bristol Myers Squibb Co | Moduladores de GPR120 de ácido fenil-(aza)cicloalquil carboxílico |
| GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
| SG11201702147TA (en) | 2014-09-17 | 2017-04-27 | Celgene Quanticel Res Inc | Histone demethylase inhibitors |
| US10030017B2 (en) | 2014-09-17 | 2018-07-24 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
| WO2016051799A1 (ja) | 2014-10-01 | 2016-04-07 | 学校法人同志社 | ２－アミノヒドロキノン誘導体及びタウ凝集阻害剤 |
| US10245254B2 (en) | 2014-10-03 | 2019-04-02 | University of Pittsburgh—of the Commonwealth System of Higher Education | Glutaminase inhibitors |
| EP3206683A4 (de) | 2014-10-16 | 2018-06-13 | The Board of Trustees of the Leland Stanford Junior University | Neuartige verfahren, verbindungen und zusammensetzungen zur anästhesie |
| DE102014116613B4 (de) | 2014-11-13 | 2023-05-04 | Osram Oled Gmbh | Optoelektronische Vorrichtung, Verwendung eines dualen Emitters als Wellenlängenkonversionsstoff |
| US20160135464A1 (en) | 2014-11-19 | 2016-05-19 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| US9540462B2 (en) | 2014-12-05 | 2017-01-10 | Massachusetts Institute Of Technology | Catechol-rich polymers from N-substituted maleimides |
| AU2015360583B2 (en) | 2014-12-10 | 2020-01-23 | The Scripps Research Institute | Small molecule inhibitors of fibrosis |
| EP3229797A4 (de) | 2014-12-12 | 2018-08-15 | Commonwealth Scientific and Industrial Research Organisation | Entfernung und freisetzung von hsc aus der knochenmarkstammzellennische mit alpha9-integrin-antagonisten |
| MA41177A (fr) | 2014-12-15 | 2017-10-24 | Esteve Labor Dr | Utilisation de ligands des récepteurs sigma dans l'arthrose |
| EP3233127A1 (de) | 2014-12-15 | 2017-10-25 | Bayer Pharma Aktiengesellschaft | Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit aglycosylierten anti-tweakrantikörpern |
| EP3034499A1 (de) | 2014-12-17 | 2016-06-22 | Gilead Sciences, Inc. | Neuartige FXR (NR1H4) modulierende Verbindungen |
| SG11201704401TA (en) | 2014-12-18 | 2017-07-28 | Hoffmann La Roche | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |
| US10633336B2 (en) | 2014-12-19 | 2020-04-28 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| WO2016105118A2 (ko) | 2014-12-24 | 2016-06-30 | 주식회사 엘지생명과학 | Gpr120 효능제로서의 바이아릴 유도체 |
| HUE055662T2 (hu) | 2014-12-29 | 2021-12-28 | Us Health | Laktát-dehidrogenáz kismolekulás inhibitorai és alkalmazási eljárásai |
| WO2016107603A1 (zh) | 2015-01-01 | 2016-07-07 | 成都贝斯凯瑞生物科技有限公司 | 取代氮杂环衍生物及其应用 |
| ES2815681T3 (es) | 2015-01-09 | 2021-03-30 | Bristol Myers Squibb Co | Ureas cíclicas como inhibidores de ROCK |
| WO2016115360A1 (en) | 2015-01-14 | 2016-07-21 | Coferon, Inc. | C-myc ligands capable of dimerizing in an aqueous solution, and methods of using same |
| JP6557977B2 (ja) | 2015-01-15 | 2019-08-14 | Jnc株式会社 | 含窒素環化合物を含有する液晶組成物および液晶表示素子 |
| KR102564925B1 (ko) | 2015-01-20 | 2023-08-07 | 아비나스 오퍼레이션스, 인코포레이티드 | 안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법 |
| US20170327469A1 (en) | 2015-01-20 | 2017-11-16 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| BR112017014065A8 (pt) | 2015-01-30 | 2022-07-19 | Hewlett Packard Indigo Bv | Composição de tinta eletrostática, método para produzir uma composição de tinta eletrostática ciana e meio de impressão |
| CA2977993A1 (en) | 2015-02-27 | 2016-09-01 | Verseon Corporation | Substituted pyrazole compounds as serine protease inhibitors |
| CA2977539A1 (en) | 2015-03-04 | 2016-09-09 | Medivation Technologies, Inc. | Sterol regulatory element-binding proteins (srebps) inhibitors |
| ES2872553T3 (es) | 2015-03-06 | 2021-11-02 | Pharmakea Inc | Inhibidores de lisil oxidasa tipo-2 y usos de los mismos |
| AU2016231174B2 (en) | 2015-03-10 | 2020-09-10 | Bayer Animal Health Gmbh | Pyrazolyl-derivatives as pest control agents |
| EP3268367B8 (de) | 2015-03-12 | 2022-11-16 | Merck Sharp & Dohme LLC | Carboxamidinhibitoren der irak4-aktivität |
| US10538491B2 (en) | 2015-03-16 | 2020-01-21 | Vanderbilt University | 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators |
| CN107529746B (zh) | 2015-03-25 | 2021-09-07 | 范德比尔特大学 | 作为orco介导的气味感觉干扰剂的二元组合物 |
| KR102598772B1 (ko) | 2015-04-03 | 2023-11-03 | 프로파제닉스 인크. | 상피 세포의 생체외 증식 |
| CN104876912B (zh) | 2015-04-08 | 2017-07-21 | 苏州云轩医药科技有限公司 | Wnt信号通路抑制剂及其应用 |
| US20180110784A1 (en) | 2015-04-09 | 2018-04-26 | The Regents Of The University Of California | Synthetic tlr4 and tlr7 ligands to prevent, inhibit or treat liver disease |
| RU2710379C2 (ru) | 2015-04-10 | 2019-12-26 | ЭфЭмСи Корпорейшн | Замещенные циклические амиды в качестве гербицидов |
| CN106146474A (zh) | 2015-04-24 | 2016-11-23 | 成都贝斯凯瑞生物科技有限公司 | 硫代咪唑二酮和咪唑二酮类化合物及其用途 |
| UY36652A (es) | 2015-04-30 | 2016-11-30 | Bayer Animal Health Gmbh | Combinaciones antiparasíticas |
| CN106279023B (zh) | 2015-05-12 | 2021-06-22 | 中国科学院上海药物研究所 | 3,4,5-三取代吡唑类化合物、制备方法、药物组合物及用途 |
| CA2979302A1 (en) | 2015-05-13 | 2016-11-17 | Selvita S.A. | Substituted quinoxaline derivatives |
| CN107835803A (zh) | 2015-05-13 | 2018-03-23 | 拜耳作物科学股份公司 | 杀昆虫的芳基吡咯烷、其制备方法及其作为试剂用于防治动物害虫的用途 |
| CA2985813A1 (en) | 2015-05-26 | 2016-12-01 | Curegenix Corporation | Tumor biomarkers and use thereof |
| CA3025813A1 (en) | 2015-05-27 | 2016-12-01 | Gb005, Inc. | Inhibitors of the tec kinase enzyme family |
| CA2983590C (en) | 2015-05-29 | 2021-11-30 | E I Du Pont De Nemours And Company | Substituted cyclic amides as herbicides |
| TW201710254A (zh) | 2015-06-01 | 2017-03-16 | 吉斯藥品公司 | 胺基酯衍生物 |
| AR104822A1 (es) | 2015-06-01 | 2017-08-16 | Chiesi Farm Spa | Derivado de aminoésteres |
| JP6949730B2 (ja) | 2015-06-02 | 2021-10-13 | エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ | 置換環状アミドおよび除草剤としてのそれらの使用 |
| EP3307728A4 (de) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | Kombinationstherapie von transkriptionshemmern und kinasehemmern |
| KR20180018808A (ko) | 2015-06-22 | 2018-02-21 | 바이엘 파마 악티엔게젤샤프트 | 효소적으로 절단가능한 기를 갖는 항체 약물 접합체 (adc) 및 항체 전구약물 접합체 (apdc) |
| WO2016207103A1 (de) | 2015-06-23 | 2016-12-29 | Bayer Pharma Aktiengesellschaft | Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-b7h3-antikörpern |
| WO2016207098A1 (de) | 2015-06-23 | 2016-12-29 | Bayer Pharma Aktiengesellschaft | Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-cd123-antikörpern |
| CA2990394A1 (en) | 2015-06-23 | 2016-12-29 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-tweakr-antibodies |
| WO2016207104A1 (de) | 2015-06-23 | 2016-12-29 | Bayer Pharma Aktiengesellschaft | Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-b7h3-antikörpern |
| EP3313399A4 (de) | 2015-06-29 | 2019-07-24 | NantBio, Inc. | Zusammensetzungen und verfahren der rit1-hemmung |
| ES2794868T3 (es) | 2015-06-30 | 2020-11-19 | Univ Texas | Inhibidores de GLS1 para el tratamiento de enfermedades |
| KR20180041135A (ko) | 2015-07-16 | 2018-04-23 | 어레이 바이오파마 인크. | Ret 키나아제 억제제로서 치환된 피라졸로[1,5-a]피리딘 화합물 |
| US10301255B2 (en) | 2015-07-22 | 2019-05-28 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| KR102086934B1 (ko) | 2015-07-29 | 2020-03-09 | 브리스톨-마이어스 스큅 컴퍼니 | 알킬 또는 시클로알킬 P2' 모이어티를 갖는 인자 XIa 마크로시클릭 억제제 |
| CN114874222A (zh) | 2015-07-29 | 2022-08-09 | 百时美施贵宝公司 | 携带非芳族p2,基团的因子xia新大环 |
| WO2017021002A1 (en) | 2015-07-31 | 2017-02-09 | Laboratorios Del Dr. Esteve, S.A. | Use of sigma receptor ligands in dyslipidemia |
| MX2018001707A (es) | 2015-08-13 | 2018-06-06 | Bayer Cropscience Ag | Novedosos compuestos para controlar artropodos. |
| WO2017049176A1 (en) | 2015-09-16 | 2017-03-23 | Metacrine, Inc. | Farnesoid x receptor agonists and uses thereof |
| WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10882847B2 (en) | 2015-09-28 | 2021-01-05 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| KR101790622B1 (ko) | 2015-10-29 | 2017-10-26 | 삼성에스디아이 주식회사 | 신규한 화합물, 신규한 폴리머 및 이를 포함하는 착색제 |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| CN105418937B (zh) | 2015-12-04 | 2018-04-13 | 福建师范大学 | 一种十二手臂单一白光星形聚合物及其制备方法 |
| MX2018005382A (es) | 2015-12-15 | 2018-08-16 | Merck Sharp & Dohme | Compuestos de biaril-monobactam y metodos de uso de los mismos para el tratamiento de infecciones bacterianas. |
| EP3190103A1 (de) | 2016-01-08 | 2017-07-12 | Rijksuniversiteit Groningen | Inhibitoren der pd-1/pd-l1-protein-/proteinwechselwirkung |
| WO2017122209A2 (en) | 2016-01-12 | 2017-07-20 | Yeda Research And Development Co. Ltd. | NF-kappaB INHIBITORS |
| US9963433B2 (en) | 2016-01-29 | 2018-05-08 | Wayne State University | Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor |
| US10189844B2 (en) | 2016-02-04 | 2019-01-29 | Chiesi Farmaceutici S.P.A. | Pyrazole derivatives as phosphoinositide 3-kinases inhibitors |
| US20190046507A1 (en) | 2016-02-18 | 2019-02-14 | Merck Sharp & Dohme Corp. | Compounds for the treatment of malaria |
| EP3416647A4 (de) | 2016-02-18 | 2019-10-23 | Merck Sharp & Dohme Corp. | N3-substituierte iminopyrimidinone als antimalariamittel |
| WO2017148518A1 (en) | 2016-03-03 | 2017-09-08 | Boehringer Ingelheim International Gmbh | 4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors |
| US20170253581A1 (en) | 2016-03-07 | 2017-09-07 | Northwestern University | SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS |
| PL3426243T3 (pl) | 2016-03-09 | 2021-10-04 | Raze Therapeutics, Inc. | Inhibitory dehydrogenazy 3-fosfoglicerynianowej i ich zastosowania |
| JP6962572B2 (ja) | 2016-03-18 | 2021-11-05 | 学校法人同志社 | ２，４−ジアミノフェノール誘導体、及び、タウ及び／又はアミロイドβの凝集阻害剤 |
| JP7251981B2 (ja) | 2016-03-24 | 2023-04-04 | バイエル ファーマ アクチエンゲゼルシャフト | 酵素開裂基を有する細胞毒性活性剤のプロドラッグ |
| CN107226805A (zh) | 2016-03-24 | 2017-10-03 | 北京天诚医药科技有限公司 | 芳香族酰胺类衍生物、其制备方法及其在医药上的应用 |
| UA123786C2 (uk) | 2016-04-06 | 2021-06-02 | Дзе Ріджентс Оф Дзе Юніверсіті Оф Мічіган | Деструктори білка mdm2 |
| ES2641860B1 (es) | 2016-04-11 | 2018-09-11 | Abengoa Research S.L. | Materiales orgánicos de transporte de huecos que contienen un líquido iónico |
| CN107312005B (zh) | 2016-04-27 | 2021-12-17 | 上海翰森生物医药科技有限公司 | 具有ido/tdo抑制活性的稠合咪唑衍生物及其制备方法和应用 |
| KR102498741B1 (ko) | 2016-04-29 | 2023-02-10 | 에프지에이치 바이오테크 인코포레이티드 | 질환 치료용 이-치환된 피라졸 화합물 |
| WO2017191098A1 (en) | 2016-05-05 | 2017-11-09 | F. Hoffmann-La Roche Ag | Pyrazole derivatives, compositions and therapeutic use thereof |
| US20170326125A1 (en) | 2016-05-16 | 2017-11-16 | Verseon Corporation | Multisubstituted aromatic compounds as inhibitors of thrombin |
| CN109153663B (zh) | 2016-05-27 | 2021-08-13 | 百时美施贵宝公司 | 作为rock抑制剂的三唑酮类化合物和四唑酮类化合物 |
| DK3464271T3 (da) | 2016-05-31 | 2020-06-15 | Kalvista Pharmaceuticals Ltd | Pyrazolderivater som plasma-kallikreininhibitorer |
| JP7094231B2 (ja) | 2016-06-06 | 2022-07-01 | エスティーブ ファーマシューティカルズ エス エイ | がんにおけるシグマ受容体リガンドの使用 |
| ES2700448R1 (es) | 2016-06-07 | 2019-02-26 | Esteve Pharmaceuticals Sa | Uso de ligandos del receptor sigma en la diabetes y el sindrome metabolico |
| US10689378B2 (en) | 2016-06-20 | 2020-06-23 | Novartis Ag | Triazolopyridine compounds and uses thereof |
| WO2018002958A1 (en) | 2016-06-30 | 2018-01-04 | Sun Pharma Advanced Research Company Limited | Novel hydrazide containing compounds as btk inhibitors |
| US10260019B2 (en) | 2016-06-30 | 2019-04-16 | The Lubrizol Corporation | Hydroxyaromatic succinimide detergents for lubricating compositions |
| WO2018005533A1 (en) | 2016-07-01 | 2018-01-04 | G1 Therapeutics, Inc. | Antiproliferative pyrimidine-based compounds |
| CN107573332B (zh) | 2016-07-05 | 2022-04-19 | 广州再极医药科技有限公司 | 芳香乙炔或芳香乙烯类化合物、其中间体、制备方法、药物组合物及应用 |
| WO2018007624A1 (en) | 2016-07-08 | 2018-01-11 | Actavis Group Ptc Ehf | Enzalutamide derivatives for the treatment of prostate and breast cancer |
| AR109024A1 (es) | 2016-07-12 | 2018-10-17 | Esteve Labor Dr | Uso de ligandos del receptor sigma en el dolor post-herpético |
| EP3486231B1 (de) | 2016-07-12 | 2020-05-20 | Guangdong Raynovent Biotech Co., Ltd. | Pyrrolidinderivat als ppar-agonist |
| EP3484879B1 (de) | 2016-07-13 | 2020-12-30 | Chiesi Farmaceutici S.p.A. | Hydroxychinolinonverbindungen mit muskarinrezeptorantagonisten- und beta2-adrenergenrezeptoragonistenaktivität |
| WO2018026371A1 (en) | 2016-08-04 | 2018-02-08 | Sunovion Pharmaceuticals Inc. | Dual nav1.2/5ht2a inhibitors for treating cns disorders |
| WO2018035072A1 (en) | 2016-08-15 | 2018-02-22 | Purdue Research Foundation | 4-substituted aminoisoquinoline derivatives |
| JP7071981B2 (ja) | 2016-09-07 | 2022-05-19 | エフジーエイチ バイオテック，インコーポレーテッド | 疾患の治療のための二置換ピラゾール化合物 |
| PT3512833T (pt) | 2016-09-15 | 2020-09-24 | Boehringer Ingelheim Int | Compostos de heteroaril carboxamida como inibidores de ripk2 |
| TWI739888B (zh) | 2016-10-07 | 2021-09-21 | 美商陶氏農業科學公司 | 農藥組合物及方法 |
| JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
| CN108602842B (zh) | 2016-11-02 | 2020-10-09 | 四川科伦博泰生物医药股份有限公司 | 杂环化合物及其制备方法和用途 |
| CN108059607B (zh) | 2016-11-09 | 2020-11-17 | 中国科学院上海药物研究所 | 亚砜基乙酸或砜基乙酸类衍生物、其药物组合物、制备方法和用途 |
| MA46760A (fr) | 2016-11-10 | 2021-06-02 | Bristol Myers Squibb Co | Modulateurs de ror gamma |
| EP3551610B1 (de) | 2016-12-08 | 2021-08-11 | Board of Regents, The University of Texas System | Bicyclo[1.1.1]pentan-inhibitoren der kinase von dualem leucin-zipper (dlk) zur behandlung von krankheiten |
| FR3060003B1 (fr) | 2016-12-09 | 2019-12-27 | L'oreal | Compose derive des 4,5-diaminopyrazoles a cycle fusionne, composition comprenant au moins un tel compose, procede de mise en oeuvre et utilisation |
| JP7174704B2 (ja) | 2016-12-21 | 2022-11-17 | バイエル・アクチエンゲゼルシヤフト | 酵素開裂基を有する細胞毒性活性剤のプロドラッグ |
| CN109071468B (zh) | 2017-01-20 | 2022-09-02 | 四川科伦博泰生物医药股份有限公司 | 一种杂环化合物及其制备方法和用途 |
| CN106831735B (zh) | 2017-01-23 | 2019-10-11 | 牡丹江医学院 | 一种治疗骨质疏松的杂环化合物及其制备方法和用途 |
| JP2020055751A (ja) | 2017-02-13 | 2020-04-09 | 味の素株式会社 | 新規化合物及び該化合物を含有する呈味改善剤 |
| WO2018152293A1 (en) | 2017-02-17 | 2018-08-23 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| EP3585775B1 (de) | 2017-02-21 | 2022-04-06 | Sanofi | Azetidin-verbindungen als gpr119-modulatoren zur behandlung von diabetes, fettleibigkeit, dyslipidämie und verwandten störungen |
| WO2018158225A1 (en) | 2017-02-28 | 2018-09-07 | Les Laboratoires Servier | Combination of a bcl-2 inhibitor and a mdm2 inhibitor, uses and pharmaceutical compositions thereof |
| JP7376358B2 (ja) | 2017-03-12 | 2023-11-08 | ワン，シャオドン | オピオイド受容体調節因子としての多環式アミン |
| CN110637011B (zh) | 2017-03-15 | 2024-05-14 | 奥加诺沃公司 | 法尼醇x受体激动剂及其用途 |
| KR101798840B1 (ko) | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
| CN107522646A (zh) | 2017-09-25 | 2017-12-29 | 福建师范大学 | 一种发光颜色可调的树枝状大分子荧光材料及其制备方法 |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| US11292782B2 (en) | 2018-11-30 | 2022-04-05 | Nuvation Bio Inc. | Diarylhydantoin compounds and methods of use thereof |
-
2019
- 2019-11-27 US US16/698,490 patent/US11034669B2/en active Active
- 2019-11-27 EP EP19889878.5A patent/EP3886854A4/de not_active Withdrawn
- 2019-11-27 AU AU2019387370A patent/AU2019387370A1/en not_active Abandoned
- 2019-11-27 WO PCT/US2019/063742 patent/WO2020113094A1/en unknown
- 2019-11-27 CA CA3121202A patent/CA3121202A1/en active Pending
-
2021
- 2021-05-23 IL IL283369A patent/IL283369A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010017902A1 (de) * | 2008-08-14 | 2010-02-18 | Bayer Cropscience Aktiengesellschaft | Insektizide 4-phenyl-1h-pyrazole |
| WO2017123542A1 (en) * | 2016-01-11 | 2017-07-20 | Janssen Pharmaceutica Nv | Substituted thiohydantoin derivatives as androgen receptor antagonists |
Non-Patent Citations (2)
| Title |
|---|
| CHANDNA NISHA ET AL: "Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents", NEW JOURNAL OF CHEMISTRY, vol. 38, no. 8, 1 January 2014 (2014-01-01), GB, pages 3662, XP055924822, ISSN: 1144-0546, DOI: 10.1039/C4NJ00226A * |
| See also references of WO2020113094A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019387370A1 (en) | 2021-06-10 |
| WO2020113094A1 (en) | 2020-06-04 |
| US11034669B2 (en) | 2021-06-15 |
| IL283369A (en) | 2021-07-29 |
| EP3886854A1 (de) | 2021-10-06 |
| CA3121202A1 (en) | 2020-06-04 |
| US20200239433A1 (en) | 2020-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3886854A4 (de) | Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung | |
| EP3684361A4 (de) | Substituierte inhibitoren von menin-mll und verfahren zur verwendung | |
| EP3919483A4 (de) | Heterocyclische benzopyridonverbindung und verwendung davon | |
| EP3684364A4 (de) | Pyridazinone und verfahren zur verwendung davon | |
| EP3816154A4 (de) | Heterocyclische verbindung und anwendung davon | |
| EP3710431A4 (de) | Substituierte pyrrolopyrimidin-jak-inhibitoren und verfahren zu ihrer herstellung und verwendung | |
| EP3849983A4 (de) | Triazolpyrimidinverbindungen und verwendungen davon | |
| EP3852533B8 (de) | Pyridazinone und verfahren zur verwendung davon | |
| EP3886853A4 (de) | Diarylhydantoiverbindungen und verfahren zur verwendung davon | |
| EP3810617A4 (de) | Ektonukleotidasehemmer und verfahren zur verwendung davon | |
| EP3749343A4 (de) | Formulierung und verfahren zur verwendung | |
| EP3829307A4 (de) | Wismuth-thiolzusammensetzungen und verwendungsverfahren | |
| EP3856214A4 (de) | Mikrobielle zusammensetzungen und verfahren zur verwendung | |
| EP3752166A4 (de) | Trialkynverbindungsmittel und verfahren zur verwendung | |
| EP3710006A4 (de) | Substituierte heteroarylverbindungen und verfahren zur verwendung | |
| EP3844280A4 (de) | Enpp1-polypeptide und verfahren zu deren verwendung | |
| EP3952876A4 (de) | Heterocyclische verbindungen und verwendungen davon | |
| EP3778593A4 (de) | Heteroarylsubstituierte pyrazolverbindung und ihre medizinische verwendung | |
| EP3952875A4 (de) | Heterocyclische verbindungen und verwendungen davon | |
| EP3810118A4 (de) | Formulierungen von tegavivint und verwandten verbindungen | |
| EP3672922A4 (de) | Wandmassen und verfahren zur verwendung | |
| EP3568018A4 (de) | Verbindungen und verfahren zur verwendung | |
| EP4034130A4 (de) | Pharmazeutische verbindungen und verfahren zur verwendung | |
| EP3887390A4 (de) | Dpep-1-bindende mittel und verfahren zur verwendung | |
| EP3740468A4 (de) | Substituierte aminopyrimidinverbindungen und verfahren zur verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210629 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031443900 Ipc: C07D0401120000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20220603 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 471/04 20060101ALI20220530BHEP Ipc: C07D 417/14 20060101ALI20220530BHEP Ipc: C07D 417/12 20060101ALI20220530BHEP Ipc: C07D 403/14 20060101ALI20220530BHEP Ipc: C07D 403/12 20060101ALI20220530BHEP Ipc: A61P 35/00 20060101ALI20220530BHEP Ipc: A61K 45/06 20060101ALI20220530BHEP Ipc: A61K 31/427 20060101ALI20220530BHEP Ipc: A61K 31/4427 20060101ALI20220530BHEP Ipc: A61K 31/4439 20060101ALI20220530BHEP Ipc: C07D 401/14 20060101ALI20220530BHEP Ipc: C07D 401/12 20060101AFI20220530BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20230103 |